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Peroxisomes are essential metabolic organelles. One of their functions is the degradation
of very long chain and long chain fatty acids by beta-oxidation. During this process, toxic
hydrogen peroxide is produced, which is degraded by the peroxisomal catalase. Due to its
ability to produce and degrade hydrogen peroxide, the organelle was named ’peroxisome’.
The importance of functional peroxisomes is highlighted by the existence of severe
human diseases that are caused by mutated peroxisomal genes. Therefore, the mainte-
nance of functional peroxisomes is essential for the cell. One important part of organellar
quality control is the maintenance of protein homeostasis. In mammals and yeast, the
peroxisomal Lon protease has protease and chaperone functions and plays a role in the
quality control of peroxisomes. The Caenorhabditis elegans homolog of the peroxiso-
mal Lon protease (LONP-2) has not been characterized so far. To study the function of
LONP-2, I generated a reporter strain expressing an unfolded protein targeted to peroxi-
somes. The unfolded protein can be stabilized in a folded state by the addition of a small
molecule ligand. Using this assay, I show that LONP-2 is like its homologs required to
degrade unfolded proteins targeted to peroxisomes.
While this represents some evidence that LONP-2 participates in the quality control of
peroxisomal matrix proteins, it remains elusive how peroxisomal quality control is regu-
lated. Quality control of other organelles has been shown to involve a retrograde signaling
from the organelle to the nucleus to activate the production of organelle-specific proteases
and chaperones in response to organelle-specific stress. In my thesis, I present evidence
of the existence of such a retrograde signaling for peroxisomes in C. elegans, which we
define as peroxisomal retrograde signaling (PRS). Specifically, I show that perturbing per-
oxisomal biogenesis by inactivating genes encoding peroxisomal biogenesis factors leads
to the transcriptional activation of the peroxisomal Lon protease lonp-2. Furthermore, the
peroxisomal catalase (ctl-2) is also up-regulated upon peroxisomal biogenesis stress. The
transcriptional activation of lonp-2 and ctl-2 is dependent on the nuclear hormone recep-
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ABSTRACT
tor NHR-49, a functional homolog of the mammalian peroxisome proliferator-activated
receptor alpha (PPARalpha), and its co-activator MDT-15. Perturbation of peroxisomal
biogenesis might lead to impaired peroxisomal lipid metabolism. We hypothesized that
the resulting change in lipid composition could act as a signal for the induction of the PRS.
Consistent with our hypothesis, knock-down of peroxisomal beta-oxidation enzymes also
induced the PRS. Proteomic analysis revealed that the activation of the PRS leads to the
up-regulation of peroxisomal beta-oxidation enzymes and proteins involved in the innate
immune response. This could represent a compensatory mechanism to maintain the per-
oxisomal function in response to peroxisomal biogenesis stress.
Peroxisomes and mitochondria are known to physically and functionally interact in
the cell. For example, metabolic pathways are shared between the two organelles. It is
conceivable that peroxisomal dysfunction also affects mitochondrial function and, hence,
induces the mitochondrial unfolded protein response. The mitochondrial unfolded pro-
tein response is a quality control pathway that induces the up-regulation of mitochondria-
specific proteases and chaperones in response to mitochondrial dysfunction. In support
of this notion, I found that knock-down of specific peroxisome biogenesis factors induces
the up-regulation of the mitochondrial chaperone hsp-6, which is a target gene of the
mitochondrial unfolded protein response. This suggests the existence of a cross-talk be-
tween the peroxisomal and mitochondrial stress responses, which could play a role in the
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1.1 The model organism Caenorhabditis elegans
In 1974, the soil nematode Caenorhabditis elegans was introduced by Sydney Brenner as
a model to study development and neurobiology [Brenner, 1974]. Since then, studying
C. elegans has contributed to our knowledge about a large variety of biological processes.
It has been shown that there is a strong conservation of cellular pathways between C. ele-
gans and mammals. Moreover, about 38% of the predicted protein-coding genes are
conserved between worms and humans [Shaye and Greenwald, 2011].
C. elegans has several advantages as a model organism. It is easy to maintain in the
laboratory: it is small (about 1 mm in length) and grows on Escherichia coli as a food
source. Moreover, C. elegans has a rapid life cycle of about three days and a short life
span of about two weeks. The developmental rate of the animals can be controlled by
growth at different temperatures (low temperatures lead to a slower development). C. ele-
gans animals mainly exists as self-fertilizing hermaphrodites, which produce hundreds of
offspring per animal. Inside the hermaphrodite, oocytes are fertilized by the sperm and the
resulting zygote starts to develop. After egg laying, the embryo further develops outside
the hermaphrodite (Figure 1.1). Then, the larva hatches and the animal develops through
four larval stages (L1-L4) into an adult hermaphrodite. Under unfavorable conditions, L2
larvae can molt into an alternative L3 larval stage, called the ”dauer” larva. In this stage,
the animals can survive several months without food. As soon as the conditions improve
and food is available, they continue their development as L4 larvae. This feature of their
life cycle is very advantageous to keep stocks of worm strains in the laboratory. Further-
more, for long-term storage, worm stocks can be frozen at -80◦C [Corsi et al., 2015].
Apart from its easy maintenance in the laboratory, C. elegans has several advantages
for experimental procedures. For example, the animals are transparent throughout their
life, which makes them very suitable for fluorescent microscopy analysis [Corsi et al.,
2015]. Another advantage is that they can be genetically modified very easily. Knock-
down of genes by RNA interference (RNAi) can be done by feeding E. coli expressing










Figure 1.1: The C. elegans life cycle. The embryo develops first within and then outside the adult
hermaphrodite. After hatching, the animals develop through four larval stages (L1-L4) into adult
hermaphrodites. Under unfavorable conditions, L2 larvae can molt into a stress-resistant ”dauer”
larva. (Figure adapted from [Altun et al., 2020]).
libraries containing bacterial strains targeting almost all predicted genes in C. elegans en-
able genome-wide RNAi screens [Kamath and Ahringer, 2003, Rual et al., 2004]. More-
over, a large number of C. elegans strains containing mutations of specific genes are avail-
able. Male animals can be generated, which enables the generation of strains with new
genotypes by crosses [Corsi et al., 2015]. Taken together, all the mentioned features (and
many others) make C. elegans a powerfull model organism to study biological processes.
1.2 Peroxisomes
Peroxisomes were first discovered in mouse kidney cells in 1954. Due to their morphol-
ogy as small cytoplasmic bodies surrounded by a single membrane, they were initially
named ’microbodies’ [Rhodin, 1954]. In the 1960’s, it was demonstrated that microbod-
ies contain enzymes required for the production and degradation of hydrogen peroxide
and, therefore, the term ’peroxisome’ was established [De Duve and Baudhuin, 1966].
Peroxisomes have tissue-specific sizes (0.1-1 µm in diameter) and enzyme compositions















Although C. elegans is a relatively simple organism, many of its genes have functional
counterparts in humans. In particular, several C. elegans homologs of mammalian perox-
isomal proteins have been identified, like for example proteins required for peroxisomal
biogenesis (see chapter 1.3.3) or peroxisomal beta-oxidation (see chapter 1.4.2) [Petriv
et al., 2002, Gurvitz et al., 2000]. In C. elegans, peroxisomes are mainly present in hypo-
dermal cells, the intestine and in the pharyngeal gland [Yokota et al., 2002, Petriv et al.,
2002]. Their size (0.1-0.3 µm in diameter) is similar to the size of the smaller type of
mammalian peroxisomes, which are present in the mammalian epithelial cells of the di-
gestive tract [Yokota et al., 2002, Novikoff and Novikoff, 1973]. All in all, the knowledge
about peroxisomes in C. elegans is limited. Several peroxisomal proteins were identified
in large scale RNAi screens. However, the phenotype caused by the knock-down of the
peroxisomal gene was only minimally described and has mostly not been investigated
further (reviewed in [Van Veldhoven and Baes, 2013]). Recently, C. elegans peroxisomes
have mainly been studied in the context of their function in the biogenesis of nematode-
specific pheromones (see chapter 1.4.2).
1.3 Peroxisome biogenesis
1.3.1 De novo peroxisome biogenesis
Peroxisomes can be formed de novo or they arise from pre-existing peroxisomes by fission
(see chapter 1.3.4). The proteins involved in peroxisomal biogenesis are called peroxins
and are encoded by the PEX genes [Distel et al., 1996]. During de novo peroxisomal
biogenesis in mammals, pre-peroxisomal vesicles containing distinct peroxins are formed
(Figure 1.2). Recently, it has been shown that vesicles budding from the outer mito-
chondrial membrane contain the membrane proteins PEX3 and PEX14. Additionally,
pre-peroxisomal vesicles containing PEX16 bud from the endoplasmic reticulum. The
two populations of vesicles fuse to form peroxisomes that can import other peroxisomal
membrane proteins (PMPs) (see chapter 1.3.2). Finally, they become import-competent
for peroxisomal matrix proteins (see chapter 1.3.3) and mature peroxisomes are formed




























Figure 1.2: De novo peroxisome biogenesis in mammals. Pre-peroxisomal vesicles containing
specific peroxisomal proteins bud from the endoplasmic reticulum and mitochondria. The vesicles
fuse to form pre-peroxisomes. Next, further peroxisomal membrane proteins are inserted. Finally,
peroxisomal matrix proteins are imported leading to the formation of mature peroxisomes. (Figure
adapted from [Kim, 2017]).
1.3.2 Insertion of peroxisomal membrane proteins
While the pre-peroxisomal vesicle contains certain PMPs, other PMPs are subsequently
inserted in the peroxisomal membrane. These PMPs contain multiple membrane per-
oxisomal targeting sequences [Jones et al., 2004]. To sort PMPs to peroxisomes, they
are bound by the cytosolic chaperone and import receptor PEX19 (Figure 1.3A) [Jones
et al., 2004]. The receptor-cargo complex docks to PEX3 at the peroxisomal membrane
[Fang et al., 2004]. The mechanism of how the PMPs are inserted into the peroxisomal
membrane is still unknown (reviewed in [Jansen and van der Klei, 2019]). PEX3 can be
targeted to peroxisomes indirectly via mitochondria (see chapter 1.3.1) [Sugiura et al.,
2017] or directly in an PEX19-dependent manner [Matsuzaki and Fujiki, 2008]. In this
case, PEX19 docks to PEX16 at the peroxisomal membrane [Matsuzaki and Fujiki, 2008].
The C. elegans genome encodes 11 homologs of the 16 human peroxins (Table 1.1)































































Figure 1.3: Import of peroxisomal proteins in mammals. (A) Insertion of peroxisomal mem-
brane proteins. PEX19 binds peroxisomal membrane proteins and brings them to the membrane.
PEX19 binds PEX3/PEX16 and the cargo is inserted in the peroxisomal membrane by an un-
known mechanism. The numbers represent the PEX proteins. (B) Peroxisomal matrix protein
import. The import receptors PEX5 or PEX7 bind peroxisomal matrix proteins containing a per-
oxisomal targeting sequence. The complex docks to the peroxisomal membrane via PEX13/14.
The cargo is translocated to the peroxisomal matrix. Finally, the receptor gets monoubiquitinated
(Ub=ubiquitin) and recycled. (Figure adapted from [Kim and Hettema, 2015]).
for other genes (pachytene exit defect), the gene class for peroxins in C. elegans is PRX.
Homologs of PEX3 and PEX19, but not of PEX16 have been identified [Thieringer et al.,
2003]. The insertion of membrane proteins has not been studied in C. elegans. However,
it has been shown that the knock-down of prx-19 leads to the block of the import of
peroxisomal matrix proteins presumably indirectly by preventing the insertion of PMPs
required for peroxisomal matrix protein import [Petriv et al., 2002].
1.3.3 Peroxisomal matrix protein import
In mammals, peroxisomal matrix proteins can be imported as monomers but also as
oligomers [Freitas et al., 2011, Otera and Fujiki, 2012]. Peroxisomal matrix proteins
are synthesized in the cytosol and recognized by the receptor PEX5, which interacts with
the C-terminal peroxisomal targeting signal 1 (PTS1) [Fransen et al., 1995] (Figure 1.3B).
The PTS1 is a tripeptide with the sequence SKL or conservative variants [Gould et al.,
1989]. Additionally, the residues upstream of the tripeptide influence the binding of
PEX5 [Lametschwandtner et al., 1998]. Some peroxisomal matrix proteins contain an
N-terminal PTS2 signal, which is recognized by the receptor PEX7 [Braverman et al.,
6
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Effect of knock-down in
C. elegans
Reference
PEX1 prx-1 No import defect [Petriv et al., 2002]
Slow growth [Simmer et al., 2003]
PEX2 prx-2 No import defect [Petriv et al., 2002]
Slow growth [Simmer et al., 2003]
PEX3 prx-3 Slow growth [Simmer et al., 2003]
PEX5 prx-5 Import defect [Petriv et al., 2002]
Larval arrest [Thieringer et al., 2003]
PEX6 prx-6 Larval arrest [Thieringer et al., 2003]
PEX7 Absent [Motley et al., 2000]
[Thieringer et al., 2003]
PEX10 prx-10 Slow growth [Simmer et al., 2003]
PEX11α ? No reference found
PEX11β ? No reference found
PEX11γ prx-11 [Thieringer et al., 2003]
PEX12 prx-12 Fewer and larger peroxisomes [Petriv et al., 2002]
Slow growth [Simmer et al., 2003]
PEX13 prx-13 Import defect [Petriv et al., 2002]
Larval arrest [Simmer et al., 2003]
PEX14 prx-14 Larval arrest [Simmer et al., 2003]
PEX16 Absent [Thieringer et al., 2003]
PEX19 prx-19 Import defect [Petriv et al., 2002]
Larval arrest [Simmer et al., 2003]















1997]. The PTS2 consists of nine amino acids and is cleaved after the import of the pro-
tein [Swinkels et al., 1991]. PEX7 interacts with a long isoform of PEX5 (PEX5L), which
acts as a co-receptor to form the receptor-cargo complex [Braverman et al., 1998]. The
complex of PEX5 with a PTS1 protein or of PEX5L-PEX7 with a PTS2 protein docks at
the peroxisomal membrane via PEX13 and PEX14 [Gouveia et al., 2000, Fransen et al.,
1998, Mukai and Fujiki, 2006]. Next, the cargo is released to the peroxisomal matrix and
the receptor is recycled for another round of import [Francisco et al., 2013]. For recy-
cling, PEX5 is monoubiquitinated at a conserved cysteine residue [Okumoto et al., 2011].
This step requires the E2 ubiquitin-conjugating enzymes UbcH5a/b/c [Grou et al., 2008]
and the RING domain proteins PEX2, PEX10 and PEX12, which have E3 ligase activities
[Okumoto et al., 2014]. The ubiquitinated receptor is exported via PEX1 and PEX6 in an
ATP-dependent manner [Miyata and Fujiki, 2005]. Finally, the receptor is deubiquitinated
by USP9X and can be used for another round of import [Grou et al., 2012].
The C. elegans genome encodes homologs for all except one peroxin required for
peroxisomal matrix protein import (Table 1.1) [Thieringer et al., 2003]. No homolog of
the receptor PEX7 has been identified and peroxisomal matrix proteins in C. elegans only
contain a PTS1 and no PTS2 is present [Motley et al., 2000]. To study if some of the
identified peroxins also represent functional homologs, the localization of CFP tagged at
its C-terminus with a PTS1 was analyzed. The knock-down of prx-5 and prx-13 led to a
redistribution of the CFP signal to the cytosol [Petriv et al., 2002, Thieringer et al., 2003].
Additionally, the interaction of PRX-5 with the peroxisomal targeting sequence SKL has
been shown by a two-hybrid assay [Gurvitz et al., 2000]. Taken together, PRX-5 likely
represents a functional homolog of the mammalian import receptor PEX5 and is required
for the import of peroxisomal matrix proteins in C. elegans.
1.3.4 Peroxisome biogenesis by growth and division
Peroxisome are not only formed de novo (see chapter 1.3.1), but peroxisomal biogene-
sis can also occur by growth and division. In mammals, this pathway requires peroxins
of the PEX11 family. First, peroxisomes are elongated in a PEX11β -dependent manner
[Delille et al., 2010]. Next, PEX11β and PEX11γ recruit the dynamin-related protein
8
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DRP1, MFF1 and FIS1, which are required for both mitochondrial and peroxisomal fis-
sion [Kobayashi et al., 2007, Koch and Brocard, 2012]. Finally, the newly formed perox-
isomes import peroxisomal membrane and matrix proteins [Kobayashi et al., 2007].
The two mechanisms of peroxisome biogenesis have not been studied in C. elegans.
However, the genome encodes a homolog of the mammalian PEX11γ [Li et al., 2002].
Moreover, it has been shown that peroxisomes are more fused in C. elegans carrying a
double mutation in the genes coding for the DRP1 and MFN1/2 homologs [Weir et al.,
2017a].
1.4 Functions of peroxisomes
1.4.1 Overview of metabolic pathways in peroxisomes
Peroxisomes are sites for various metabolic pathways (Figure 1.4). For example, fatty
acids are degraded by peroxisomal alpha- and beta-oxidation (see chapter 1.4.2). The
products of the beta-oxidation pathway either exit the peroxisome for final degradation in
mitochondria or they serve as substrates for various biosynthesis pathways (reviewed in
[Wanders et al., 2016]). These pathways include the synthesis of bile acids from choles-
terol. Bile acids participate in the digestion and adsorption of fat [Pedersen and Gustafs-
son, 1980]. Another anabolic pathway taking place in peroxisomes is the synthesis of
etherphospholipids, which are found in most mammalian cellular membranes [Heymans
et al., 1983]. The major class of etherphospholipids in mammals are plasmalogens, which
are especially enriched in the myelin sheath in the nervous tissue and are required for
normal nervous system function [Macala et al., 1983, Brites et al., 2009]. Furthermore,
plasmalogens are required for the storage of polyunsaturated fatty acids, which are also
synthesized in peroxisomes [Ferdinandusse et al., 2003]. Additionally, peroxisomes are
required for the metabolism of some amino acids [Van Veldhoven et al., 1991, De Duve
and Baudhuin, 1966, Wanders et al., 1989] and the detoxification of glyoxylate, which is
formed in the intermediary metabolism of glycine [Danpure and Jennings, 1986]. Fur-







































Figure 1.4: Selected metabolic pathways in peroxisomes. Peroxisomal beta-oxidation is re-
quired for the degradation of fatty acids or to generate substrates for other metabolic pathways.
Reactive oxygen species (ROS) or reactive nitrogen species (RNS) are produced as byprod-
ucts of the metabolic pathways. Therefore, peroxisomes contain several antioxidant systems.
(PUFA=Polyunsaturated fatty acid).
Many metabolic pathways in peroxisomes produce hydrogen peroxide, superoxide or
nitric oxide as byproducts (Figure 1.4). Therefore, peroxisomes contain several antioxi-
dant enzymes. One example is the peroxisomal catalase, which catalyzes the reaction of
hydrogen peroxide to water and oxygen. It protects the cell from toxic peroxides gen-
erated in peroxisomes [Siraki et al., 2002]. The inhibition of catalase in rats leads to an
accumulation of hydrogen peroxide in peroxisomes and thus to a reduction of the activ-
ity of thiolase, which is an peroxisomal beta-oxidation enzyme [Hashimoto and Hayashi,
1987]. In contrast, analysis of a C. elegans strain harboring a deletion of the peroxiso-
mal catalase gene ctl-2 showed that the size of lipid droplets accumulated in the cells is
not changed compared to wild-type cells. From these observations, the authors conclude
that fat metabolism is not changed in the ctl-2 mutants. However, the mutation leads to a
change in peroxisomal morphology and a decreased life span of the animals [Petriv and
Rachubinski, 2004]. Another enzyme that degrades hydrogen peroxide in mammalian
peroxisomes is the peroxiredoxin 5 [Walbrecq et al., 2015]. To degrade superoxide, per-
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oxisomes contain a Cu,Zn superoxide dismutase [Keller et al., 1991]. Furthermore, the
glutathione S-transferase kappa 1 contributes to lipid peroxide detoxification in mam-
malian cells [Wang et al., 2013]. C. elegans expresses several ROS metabolizing enzymes
and among them also homologs of superoxide dismutases and peroxiredoxins. However,
the catalase CTL-2 is the only enzyme that has been shown to localize to peroxisomes
(reviewed in [Miranda-Vizuete and Veal, 2017]).
1.4.2 The peroxisomal beta-oxidation pathway
Peroxisomal beta-oxidation in mammals
One important metabolic function of peroxisomes is the degradation of very long-chain
and long-chain fatty acids by peroxisomal beta-oxidation. Prior to their degradation, the
fatty acids are activated by the attachment of coenzyme A (CoA). The reaction is catalyzed
by various acyl-CoA synthetases, which are localized outside and also inside peroxisomes
[Steinberg et al., 1999, Watkins et al., 2007] (Figure 1.5). The fatty acids are transported
into peroxisomes by ABC class D transporters. It is still under debate if free fatty acids or
the activated CoA esters are transported [van Roermund et al., 2011, van Roermund et al.,
2014]. 3-methyl-branched fatty acids first have to undergo one cycle of alpha-oxidation
before they can enter the peroxisomal beta-oxidation pathway (reviewed in [Jansen and
Wanders, 2006]). One cycle of peroxisomal beta-oxidation reduces the fatty acid chain by
two (or three) carbon atoms and leads to the release of one acetyl-CoA (or propionyl-CoA)
molecule in a four step enzymatic reaction. During the first, rate-limiting step acyl-CoA
is dehydrogenated to 2-trans-enoyl-CoA thereby producing hydrogen peroxide, which is
subsequently degraded by the peroxisomal catalase. This reaction is catalyzed by acyl-
CoA oxidases (ACOX). In humans, ACOX1 is required for the oxidation of straight-chain
fatty acids, whereas ACOX2 and ACOX3 are involved in the degradation of 2-methyl-
branched-chain fatty acids [Vanhove et al., 1993, Ferdinandusse et al., 2018]. The next
two steps of hydratation and dehydrogenation of the substrate are catalyzed by one of the
two so-called bifunctional enzymes (MFP1 and MFP2). Both enzymes can act on straight-















the two enzymes show different stereospecificity [Palosaari and Hiltunen, 1990, Jiang
et al., 1997]. The final step of peroxisomal beta-oxidation involves a thiolytic cleavage
of the substrate by either the straight-chain specific 3-oxo-acyl thiolase (ACAA1) [Bout


















































































Figure 1.5: The peroxisomal beta-oxidation pathway. Very long chain fatty acids are imported
into peroxisomes and degraded by a four step reaction. First, the activated fatty acids are oxidized
by acyl-CoA oxidases. The next two steps are catalyzed by the bifunctional enzyme. Finally,
the substrate is cleaved by a thiolase. Potential C. elegans homologs of the enzymes are shown.
However, only for a subset of these homologs the function in peroxisomal beta-oxidation has been
shown experimentally.
Peroxisomal beta-oxidation in C. elegans
Studies using computer-based and experimental approaches revealed that the peroxisomal
beta-oxidation enzymes are conserved from yeast and human to C. elegans [Petriv et al.,
2002, Gurvitz et al., 2000]. The function of the C. elegans beta-oxidation enzymes has
mainly been studied in the context of the biosynthesis of a class of pheromones called
12
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‘ascarosides’. These pheromones regulate various behaviors such as the induction of
the stress-resistant dauer larval stage, aggregation and mating behavior [Butcher et al.,
2007, Golden and Riddle, 1982, Srinivasan et al., 2012, Srinivasan et al., 2008a]. The
different biological activities of ascarosides are associated with various chemical modifi-
cations of the molecules. Ascarosides are derivatives of the 3,6-dideoxysugar-ascarylose
attached to a fatty acid side chain at the (ω-1)- or ω-position. Moreover, additional
modifications can occur at the sugar (head groups) or at the end of the side chain (ter-
minal group) [Hollister et al., 2013]. A variety of ascarosides with different side-chain
lengths can be produced by the shortening of long-chain precursors by peroxisomal beta-
oxidation (Figure 1.5). Homologs of the human ABC class D transporters are encoded
by five pmp genes. However, only PMP-1, PMP-2 and PMP-4 have been shown to lo-
calize to peroxisomes [Lee et al., 2014]. The first step of peroxisomal beta-oxidation is
catalyzed by acyl-CoA oxidases (ACOX-1.1 to ACOX-1.6 and ACOX-3), which show
preferences in the processing of different ascarosides [Joo et al., 2010, von Reuss et al.,
2012, Zhang et al., 2016, Zhang et al., 2018]. MAOC-1 and DHS-28 are functional ho-
mologs of the mammalian bifunctional enzyme MFP2 and catalyze the next two steps
of the beta-oxidation cycle [Zhang et al., 2010, von Reuss et al., 2012, Butcher et al.,
2009]. Finally, the substrate is cleaved by DAF-22, which encodes a homolog of the thi-
olase domain of human SCPx [Butcher et al., 2009]. Three ORFs have been predicted
to represent orthologs of the human peroxisomal thiolase ACAA1 [Petriv et al., 2002].
However, only KAT-1 has a functional peroxisomal targeting sequence and additionally
a mitochondrial targeting sequence [Mak et al., 2006]. The described DHS-28/MAOC-
1/DAF-22 beta-oxidation pathway has not only been implicated in the biosynthesis of
ascarosides, but also in the degradation of triacylglyerols [Zhang et al., 2010, von Reuss
et al., 2012, Artyukhin et al., 2018]. Additionally to the described enzymes, the C. elegans
genome comprises further genes predicted by sequence homology to code for peroxiso-
















Transcriptional regulation of the peroxisomal beta-oxidation
In mammals, metabolic pathways in peroxisomes are regulated by a subfamily of nuclear
receptors: the peroxisome proliferator activated receptors (PPARs). The peroxisomal
and mitochondrial beta-oxidation is regulated by the member PPARα [Aoyama et al.,
1998]. PPARs act as a ligand-activated transcription factors, which form heterodimers
with retinoid X receptors (RXR) and bind to PPAR response elements, which are specific
DNA regions located 5’ of the target genes (Figure 1.6) [Keller et al., 1993, Tugwood
et al., 1992]. The receptors can be activated by a broad spectrum of ligands, which can be
natural compounds like fatty acids, eicosanoids or phospholipids. Furthermore, there is
also a broad range of synthetic ligands, so called peroxisome proliferators [Keller et al.,
1993, Forman et al., 1997, Kliewer et al., 1997]. The ligands are transported to the nucleus
by fatty acid binding proteins [Hostetler et al., 2009]. The transcriptional regulation of
PPAR target genes depends on the binding of co-factors. More than 300 co-activators and
co-repressors have been identified so far (reviewed in [Viswakarma et al., 2010]). Ligand
binding to the PPAR-RXR heterodimer leads to a conformational change, which promotes
the release of co-repressor proteins and the binding of co-activator proteins [Dowell et al.,
1999].











Figure 1.6: Transcriptional regulation by the peroxisome proliferator activated receptor alpha
(PPARα). Fatty acid binding proteins bring the ligands to PPARα . It forms a heterodimer with
the retinoid X receptor (RXR) and binds to the PPAR response element (PPRE), which is located
up-stream of the PPARα target genes. Ligand binding to the PPARα-RXR heterodimer leads to
a conformational change, which promotes the release of co-repressor proteins and the binding of
co-activator proteins. (Figure adapted from [Ehrenborg and Krook, 2009]).
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In C. elegans, the nuclear hormone receptor NHR-49 is required for the regulation
of lipid metabolism. Therefore, it was suggested that it is a functional homolog of
PPARα , although it is a sequence homolog to the hepatocyte nuclear factor 4 [Gilst et al.,
2005]. Similar to PPARα , NHR-49 interacts with different co-factors to regulate specific
metabolic pathways. The nuclear hormone receptors NHR-13, NHR-22, NHR-66 and
NHR-105 as well as the Mediator subunit MDT-15 were identified as NHR-49 co-factors
in yeast-two hybrid screens. Additionally, the nuclear hormone receptors NHR-66 and
NHR-80 show a physical interaction with NHR-49 in vitro. The physical interaction was
also reflected in functional studies. The interaction of NHR-49 and NHR-66 is required
for the regulation of sphingolipid metabolism and lipid remodeling, whereas the NHR-
49/NHR-80 and NHR-49/NHR-13 heterodimers regulate fatty acid desaturation [Pathare
et al., 2012]. Additionally, an interaction of NHR-49 with MDT-15 is also implicated the
regulation of the expression of fatty acid desaturases. Furthermore, the NHR-49/MDT-15
heterodimer is controlling genes involved in the fasting response [Taubert et al., 2006].
Similar to the mammalian fatty acid binding proteins, the C. elegans lipid binding pro-
teins LBP-5 and LBP-8 have been shown to bind fatty acids and to regulate NHR-49 target
genes [Xu et al., 2011, Folick et al., 2015].
1.4.3 The role of peroxisomes in the immune response
Peroxisomal metabolism is also required for the regulation of inflammation and immune
functions. For example, peroxisomes play a role in the anti-inflammatory response in
mammalian macrophages. The knock-down of the peroxin PEX14 or the peroxiso-
mal beta-oxidation enzyme MFP2 leads to an enhanced inflammatory response due to
an increase of pro-inflammatory proteins [Vijayan et al., 2017]. Moreover, the anti-
inflammatory response in mammalian macrophages is dependent of peroxisome prolif-
erator activated receptors (PPARs) [Chang et al., 2015, Devchand et al., 1996]. Di Cara et
al. analyzed the effect of the loss of the peroxisomal import receptors PEX5 and PEX7 on
phagocytosis in murine and Drosophila macrophages. Disruption of peroxisomal import
leads to a decreased phagocytosis of bacteria upon infection. However, phagocytosis can















isomes. Moreover, infection leads to a transcriptional up-regulation of genes encoding
enzymes for lipid metabolism in Drosphila [Di Cara et al., 2017].
Several known human pathogens can also infect the intestine of C. elegans. There-
fore, it is a good model organism to study host-pathogen interactions. For example the
Gram-negative bacterium Pseudomonas aeruginosa is pathogenic to C. elegans and hu-
mans [Tan et al., 1999]. However, the C. elegans immune system is less complex than the
immune system of other invertebrates or mammals. C. elegans lacks an adaptive immune
system and specialized immune cells. Furthermore, only the most ancestral signaling
networks of the innate immunity are conserved. For instance, the role of the p38 MAP ki-
nase pathway in the innate immune response is conserved between C. elegans and humans
[Kim et al., 2002]. In contrast, no C. elegans homologs of the NF-κB family of transcrip-
tion factors have been identified and homologs of the Drosophila Toll pathway are not re-
quired for the resistance to pathogens [Pujol et al., 2001]. The C. elegans innate immune
system induces the secretion of several antimicrobial proteins upon pathogen infection.
These proteins include C-type lectins, DUF274 proteins, lysozymes, collagens and UDP-
glucosyltransferases [Simonsen et al., 2012]. Furthermore, extracellular reactive oxygen
species are produced in the intestinal lumen to fight infection by the pathogenic bacterium
Enterococcus faecalis [Chávez et al., 2007, Chávez et al., 2009, Hoeven et al., 2011]. The
peroxisomal catalase CTL-2 and the mitochondrial Cu/Zn superoxide dismutase SOD-3
are required for the resistance to the pathogen infection, presumably to protect the intesti-
nal cells from the cytotoxic ROS [Chávez et al., 2007]. The requirement of CTL-2 for
the resistance to E. faecalis infection shows that peroxisomes are involved in the innate
immune response in C. elegans. Moreover, the PPARα homolog NHR-49 is required
for the survival on E. faecalis [Sim and Hibberd, 2016]. Since NHR-49 is an important
regulator of fat metabolism, it is conceivable that, similar to mammals and Drosophila,




The importance of peroxisomes in human metabolism is highlighted by the existence
of severe genetic diseases called peroxisomal disorders. These rare diseases either lead
to a perturbation of peroxisomal function because peroxisomes lack a specific enzyme
(single peroxisomal enzyme deficiencies) or they interfere with peroxisomal biogenesis
(peroxisome biogenesis disorders) (reviewed in [Wanders, 2018]). To get a more compre-
hensive picture of peroxisomal disorders, various peroxisome deficient model organisms
have been studied [Hiebler et al., 2014, Baes et al., 1997, Fan et al., 1996, Mast et al.,
2011]. The model organism C. elegans also has been proposed to be suitable to study
peroxisomal biogenesis disorders [Thieringer et al., 2003, Coppa et al., 2020].
While peroxisome biogenesis disorders cause abnormalities in many peroxisomal
metabolic pathways, single peroxisomal enzyme deficiencies affect only one specific
pathway [Wangler et al., 2018]. Therefore, they are classified according to the metabolic
pathway that is affected. The X-linked adrenoleukodystrophy is with a prevalence of
1:20,000 to 1:30,000 incidences the most common peroxisomal disorder [Wiesinger et al.,
2015]. X-linked adrenoleukodystrophy leads to an accumulation of very long chain fatty
acids due to a mutation in the gene ABCD1, which is coding for a peroxisomal half-ABC
transporter [Igarashi et al., 1976, Mosser et al., 1993]. Five other diseases caused by
mutations in enzymes or transporters required for peroxisomal beta-oxidation have been
described so far [Ferdinandusse et al., 2000, Ferdinandusse et al., 2006a, Ferdinandusse
et al., 2006b, Ferdinandusse et al., 2007, Ferdinandusse et al., 2017]. Furthermore, sin-
gle peroxisomal enzyme deficiencies affect peroxisomal alpha-oxidation [Jansen et al.,
1997], etherphospholipid biosynthesis [Ofman et al., 1998, Buchert et al., 2014], glyoxy-
late metabolism [Danpure et al., 1994, Frishberg et al., 2014], bile acid synthesis [Vilar-
inho et al., 2016, Ferdinandusse et al., 2014, Hadžić et al., 2012] and hydrogen peroxide
metabolism [Takahara, 1952].
Peroxisome biogenesis disorders occur due to mutations in one of the 13 PEX genes
(Zellweger spectrum disorders (reviewed in [Waterham and Ebberink, 2012]), Rhizomelic















or due to deficiencies of proteins required for peroxisomal fission [Waterham et al.,
2007, Koch et al., 2016]. The severity of the disorders correlates with the predicted con-
sequence of the mutation on the protein function and its effect on peroxisomal matrix
protein import and peroxisome number [Rosewich et al., 2005, Matsumoto et al., 2003].
The Zellweger spectrum disorders display a broad clinical heterogeneity. Some patients
present severe phenotypes like neuronal migration defects and liver dysfunction leading
to a high mortality within the first years of life [Govaerts et al., 1982], whereas patients
with a mild form of Zellweger spectrum disorder survive until adulthood [Berendse et al.,
2016].
1.6 Protein quality control of different organelles
1.6.1 Protein quality control mechanisms
The maintenance of proteostasis is essential for the cell. The accumulation of misfolded
proteins or protein aggregates often leads to neurodegenerative diseases like Alzheimer’s
disease or Parkinson’s disease. To maintain proteostasis, chaperones assist the refolding
of proteins and prevent their aggregation. Moreover, misfolded proteins can be degraded
by proteases or by the proteasome. If proteins form aggregates or escape the surveillance
of the proteasome system, they are degraded by the lysosome via the autophagy pathway
(reviewed in [Chen et al., 2011]). Specific stress response pathways exist for the differ-
ent organelles. For example, the endoplasmic reticulum or mitochondria induce unfolded
protein response pathways upon the accumulation of misfolded proteins or protein ag-
gregates. These pathways induce a retrograde signal from the organelle to the nucleus.
The signal leads to the up-regulation of effector genes (among others organelle-specific
chaperones or proteases), which contribute to restore the organelle’s function (reviewed
in [Almanza et al., 2019, Melber and Haynes, 2018]). In this chapter, I will focus on the
peroxisomal and mitochondrial protein quality control mechanisms.
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1.6.2 Peroxisomal protein quality control
Peroxisomal protein quality control includes the removal of non-functional proteins by the
AAA+ ATPases Msp1 and the peroxisomal Lon protease. In S. cerevisiae, quality control
of peroxisomal membrane proteins depends on Msp1, which is localized to peroxisomes
and mitochondria. Weir et al. analyzed the effect of the over-expression of the peroxiso-
mal membrane protein Pex15. A fraction of Pex15 mislocalized to mitochondria, where it
was rapidly degraded in an Msp1-dependent manner. Additionally, over-expressed Pex15
that localized to the peroxisomal membrane was first also degraded by Msp1. However,
Pex15 rapidly adapted an Msp1-insensitive state. The authors suggested that at the per-
oxisomal membrane Pex15 is stoichiometrically protected by Pex3 [Weir et al., 2017b].
Although Msp1 is conserved between the species, its function in peroxisomal quality
control has only been studied in S. cerevisiae.
Quality control of peroxisomal matrix proteins requires the peroxisomal Lon protease.
It was first identified in rat liver cells and shows structural and functional similarities to
the mitochondrial Lon protease [Kikuchi et al., 2004, Bartoszewska et al., 2012]. Analy-
sis of the peroxisomal Lon protease in several model organisms suggests that it is required
for the degradation of peroxisomal metabolic enzymes [Aksam et al., 2007, Yokota et al.,
2008, Bartoszewska et al., 2012, Goto-Yamada et al., 2014]. Furthermore, the degradation
of an artificially over-expressed unfolded protein targeted to peroxisomes also requires the
peroxisomal Lon protease [Aksam et al., 2007]. In line with these observations, in vitro
studies revealed that the peroxisomal Lon protease has chaperone and ATP dependent
protease activity [Bartoszewska et al., 2012, Aksam et al., 2007, Omi et al., 2008]. Ad-
ditionally, the peroxisomal Lon protease cooperates with autophagy in the degradation
of non-functional peroxisomes in some organisms. In the plant Arabidopsis thaliana,
knock-out mutants of the peroxisomal Lon protease show increased autophagy [Goto-
Yamada et al., 2014, Farmer et al., 2013]. Furthermore, in mammalian cells that were
pre-treated by a peroxisome proliferator two observations were made: peroxisomal beta-
oxidation enzymes were degraded by the peroxisomal Lon protease [Yokota et al., 2008]















yeast Hansenula polymorpha and in the filamentous fungus Penicillium chrysogenum,
the peroxisomal number is not changed in peroxisomal Lon protease mutants indicating
that autophagy is not induced [Aksam et al., 2007, Bartoszewska et al., 2012]. All in
all, the different studies suggest that some functions of the peroxisomal Lon protease are
conserved, whereas other are organism-specific. The C. elegans gene lonp-2 encodes a
homolog of the peroxisomal Lon protease. However, its function has not been character-
ized so far.
1.6.3 The mitochondrial unfolded protein response
Mitochondria synthesize ATP by oxidative phosphorylation, are involved in programmed
cell death and are sites for various metabolic pathways. Recently, it has been shown that
perturbation of many (but not all) mitochondrial functions can induce the mitochondrial
unfolded protein response (UPRmt) [Rolland et al., 2019]. This stress response pathway
induces the up-regulation of mitochondrial chaperones and proteases to restore the or-
ganelle’s function. While the UPRmt was discovered in mammalian cells [Martinus et al.,
1996], many of the components of the pathway were identified in C. elegans. The induc-
tion of UPRmt in C. elegans is regulated by the bZip transcription factor ATFS-1, which
has a nuclear localization signal and a mitochondrial targeting sequence [Haynes et al.,
2010]. Under physiological conditions, ATFS-1 is imported into mitochondria, where it is
degraded by the mitochondrial Lon protease (Figure 1.7) [Nargund et al., 2012]. In case
of mitochondrial dysfunction, non-functional proteins are cleaved by the protease CLPP-
1 and exported to the cytosol by the ABC transporter HAF-1 [Haynes et al., 2007, Haynes
et al., 2010]. It has been proposed that HAF-1 modulates mitochondrial import and thus
the import of ATFS-1 [Nargund et al., 2012]. Additionally, most inducers of UPRmt di-
rectly or indirectly perturb mitochondrial import [Nargund et al., 2012, Rolland et al.,
2019]. Thus, ATFS-1 can no longer enter mitochondria, where it is degraded, but translo-
cates to the nucleus, where it activates the transcription of genes required for among oth-
ers mitochondrial quality control, detoxification, immunity or metabolism [Haynes et al.,
2010, Nargund et al., 2012]. Additionally to ATFS-1, the induction of UPRmt requires
the transcription factor DVE-1 and its co-factor UBL-5 [Benedetti et al., 2006, Haynes
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et al., 2007]. Furthermore, a complementary pathway that regulates cytosolic protein
synthesis in response to mitochondrial stress exists. Mitochondrial dysfunction leads to
the production of ROS, which activates the kinase GCN-2. The translation initiation fac-
tor eIF2α is phosphorylated by GCN-2, which leads to translational attenuation and, thus,






























Figure 1.7: The mitochondrial unfolded protein response in C. elegans. The transcription factor
ATFS-1 has a nuclear localization signal (NLS) and a mitochondrial targeting sequence (MTS).
Upon activation of UPRmt, ATFS-1 is no longer degraded by the mitochondrial Lon protease. To-
gether with UBL-5 and DVE-1, it translocates to the nucleus, where they activate various stress
response genes. As a complementary pathway, reactive oxygen species (ROS) produced by dys-
functional mitochondria activate the kinase GCN-2. This leads to the phosphorylation of eIF2α
and by this to a change in protein translation. (Figure adapted from [Jovaisaite et al., 2014]).
The UPRmt pathway is partially conserved from C. elegans to humans. In contrast
to C. elegans, translational control by phosphorylated eIF2α is a prerequisite for the in-
duction of mammalian UPRmt. This results in an increased expression of ATF5, which
is the functional homolog of the C. elegans transcription factor ATFS-1 and also har-
bors a nuclear localization signal and a mitochondrial targeting sequence [Zhou et al.,
2008, Fiorese et al., 2016]. The up-regulation of ATF5 requires the transcription fac-
tors ATF4 and CHOP, which both are also targets of eIF2α phosphorylation [Zhou et al.,
2008, Teske et al., 2013]. However, the functional interaction of ATF4, ATF5 and CHOP
in the regulation of UPRmt is not known. It has been shown that, similar to ATFS-1, ATF5
translocates to the nucleus upon mitochondrial dysfunction and activates mitochondria-
specific stress response genes encoding for example chaperones like HSP60 or mitochon-















1.7 Aim of this study
The importance of functional peroxisomal biogenesis is highlighted by the existence of se-
vere human disorders caused by mutations in the PEX genes. Studying these diseases has
significantly contributed to our understanding of the biology of peroxisomes. In general,
these studies focus on peroxisomal defects caused by mutations. However, like for other
organelles, the function of initially healthy peroxisomes can also get disrupted during the
life of an organism. If the defect is not too severe one can speculate that a peroxisome-
specific stress response pathway could be activated to restore the peroxisome’s function
like it has been shown for other organelles. Such a peroxisomal stress response pathway
has not been described so far. However, it has been shown that the peroxisomal Lon
protease can contribute to protein homeostasis by degrading misfolded proteins. Further-
more, it can act as a chaperone and contribute to the folding of proteins. This indicates
that the peroxisomal Lon protease is part of a peroxisomal quality control system. Thus,
it may be also part of a peroxisomal stress response pathway.
C. elegans is a suitable organism to study organellar stress response pathways. For
example, the mitochondrial unfolded protein response has extensively been studied in
C. elegans. Although it was first discovered in mammals, subsequent work was mostly
done in C. elegans identifying several components of the pathway. Later, it has been
shown that many of these components are conserved in humans. Therefore, we used
C. elegans as a model organism to study the peroxisomal stress response. In contrast to
mitochondria, the knowledge about peroxisomes in this organism is limited. However,
it has been shown that many components of the peroxisomal biogenesis are conserved
from humans to C. elegans. Furthermore, the peroxisomal beta-oxidation, which is an
important function of peroxisomes, is also conserved between the species.
The first aim is to characterize the peroxisomal Lon protease LONP-2 in C. elegans.
So far, it has not been studied if LONP-2 also has protease and chaperone functions, like
it was shown for other organisms. Therefore, I will analyze if the C. elegans peroxisomal
Lon protease is required for the degradation of an unfolded protein and might therefore
be required for the peroxisomal stress response pathway.
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Stress response pathways induce a retrograde signaling from the organelle to the nu-
cleus to up-regulate specific target genes to restore the organelle’s function. A similar
pathway may exist in peroxisomes and the peroxisomal Lon protease might be a target
gene for a peroxisomal retrograde signaling. The main aim of my study is to analyze if
a peroxisomal retrograde signaling exists in C. elegans and to characterize the different
components of the pathway.
Peroxisomes and mitochondria are known to physically and functionally interact in the
cell. For example, metabolic pathways are shared between the two organelles. Moreover,
it has been shown in mammals that perturbation of peroxisomal function also affects mi-
tochondrial function. Therefore, the third aim of my thesis is to analyze if a perturbation


















2. MATERIALS AND METHODS
2.1 Strains and general maintenance of C. elegans
C. elegans strains were cultured as previously described [Brenner, 1974]. Animals were
maintained at 15◦C, 20◦C or 25◦C on nematode growth medium (NGM) plates with Es-
cherichia coli OP50 bacterial lawns [Stiernagle, 2006]. Bristol N2 was used as the wild-
type strain. The prx-5(tm4948) allele was obtained from the National BioResource Project
(https://shigen.nig.ac.jp/c.elegans/). The daf-22(m130) [Golden and Riddle, 1985] and
ctl-2(ua90) [Petriv and Rachubinski, 2004] alleles were obtained from the Caenorhabdi-
tis Genetics Center (https://cgc.umn.edu/). The strains used in this study are summarized
in Table 2.1.
Table 2.1: C. elegans strains used in the study.


















MD4601 bcSi112 IV Pdaf-22YFP::dhfr







MD3919 bcIs126 I Plonp-2GFP (pBC1503) Generated for my
Master thesis
MD3920 bcIs128 I Plonp-2GFP (pBC1503) Generated for my
Master thesis
MD4247 bcSi75 IV Plonp-2GFP (pBC1743) This study
MD4253 bcSi76 IV Pctl-2GFP (pBC1744) This study
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Table 2.1 continued from previous page
Strain Genotype Transgene description Reference
MD4581 bcSi110 Pdaf-22GFP (pBC1905) This study
SJ4100 zcIs13 V Phsp-6GFP [Yoneda et al., 2004]
SJ4058 zcIs9 V Phsp-60GFP [Yoneda et al., 2004]
MD4202 tm4948 II prx-5(tm4948) This study
MD4211 bcIs126 I;
tm4948 II
Plonp-2GFP carrying prx-5(tm4948) This study
MD4212 bcIs126 I Plonp-2GFP This study
MD4292 tm4948 II;
bcSi76 IV
Pctl-2GFP carrying prx-5(tm4948) This study
MD4293 bcSi76 IV Pctl-2GFP This study
MD4304 gk405 I nhr-49(gk405) This study
MD4464 m130 II;
bcSi76 IV
Pctl-2GFP carrying daf-22(m130) This study
MD4465 bcSi76 IV Pctl-2GFP This study
MD4475 bcIs126 I;
m130 II
Plonp-2GFP carrying daf-22(m130) This study
MD4381 bcIs126 I;
ua90 II
Plonp-2GFP carrying ctl-2(ua90) This study
MD4665 ua90 II;
bcSi76 IV
Pctl-2GFP carrying ctl-2(ua90) This study
MD4664 bcSi76 IV Pctl-2GFP This study
2.2 Generation of transgenic animals
2.2.1 Reporters to visualize peroxisomes by fluorescent microscopy
The membrane of peroxisomes in hypodermal cells was labeled by a fusion construct of






















2. MATERIALS AND METHODS
plified by PCR using the primers mkate2PTS1FNheI1 and mkate2-linker-R (Table 2.2).
The fusion construct linker::pxmp-4 was amplified from the plasmid pBC1574 using
the primers mkate2-linker-F and PMP24R-KpnI. The mKate2 and linker::pxmp-4 frag-
ments were fused by overlap extension PCR using the primers mkate2PTS1FNheI1 and
PMP24R-KpnI. To generate the plasmid pBC1699, the obtained PCR product was first
cloned into the EcoRV site of pBluescript KS(+) (Stratagene) and then sub-cloned into
the NheI and KpnI sites of pBC1666, which contains the vha-7 promoter and an unc-54
3’UTR.
The matrix of peroxisomes in hypodermal cells was labeled by a GFP::PTS1 construct.
The primers GFPPTS1F-KpnI and gftpts1R-new were used to amplify GFP from the
plasmid pPD118.60 (a gift from Andrew Fire; Addgene plasmid no. 1598) and thereby to
fuse the PTS1 SKL to GFP. The PCR product was cloned into the EcoRV site of pBlue-
script KS(+) (Stratagene), generating the plasmid pBC1572. The GFP::PTS1 construct
was sub-cloned into the KpnI and SacI sites of the plasmid pBC970, which contained the
vha-7 promoter and an unc-54 3’UTR. The final plasmid was named pBC1578.
The plasmids pBC1699 (1 ng/µl) and pBC1578 (1 ng/µl) were co-injected into
MT1642(lin-15(n765ts)), using the lin-15 rescue plasmid pL15.EK (50 ng/µl) as a co-
injection marker. The obtained extrachromosomal array bcEx1310 was integrated by UV
treatment. The Pvha-7GFP::PTS1 and Pvha-7mKate2::pxmp-4 (bcIs140; lin-15(n765ts))
reporter strain was back-crossed five times with MT1642.
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Table 2.2: Primers used in the study.
Name Sequence (5’-3’)
mkate2PTS1FNheI1 GCT AGC ATG TCC GAG CTC ATC AAG GAG
mkate2-linker-R GGG AGC GCA GGC CGG AAC GGT GTC CGA GCT TG
mkate2-linker-F CAA GCT CGG ACA CCG TTC CGG CCT GCG CTC CC
PMP24R-KpnI GGT ACC CTA TGG ATG GAA TTC GAA TAG CC
GFPPTS1F-KpnI GGT ACC ATG AGT AAA GGA GAA GAA CTT TTC
gftpts1R-new GAA TTC TTA AAG TTT GGA ATG AAG AGG TTT G
Pdaf22-F AAG CTA CGT AAT ACG ACT CAA TGG CTT TAC CAC
CAA TTG
Pdaf22-mKate2-R GAG CTC GGA CAT TTT TCT GGA ACA ATA TTT TTT
TTT CGA AG
Pdaf22-mKate2-F TTG TTC CAG AAA AAT GTC CGA GCT CAT CAA GGA G
mKate2-UTR-R TGG TTG GCG TCA TGG AGT TGG ACG CCT GCG C
mKate2-UTR-F GCG TCC AAC TCC ATG ACG CCA ACC AAG CCA AAG
Pdaf22-GFP-F AAA AAT ATT GTT CCA GAA AAA TGA GTA AAG GAG
AAG AAC
PXMP4-UTR-R TTA AAT TAT TCC GTT TTT ATT TGG ATG GAA TTC
GAA TAG
daf22-UTR-R CGC GAT GCA TTC GAA GAT CTG CCC AAG TTA GTT
TTT TAC TAG AAG CTG CC
Pdaf22-DHFR-R TGC TCA CCA TTT TTC TGG AAC AAT ATT TTT TTT TC
Pdaf22-DHFR-F TTC CAG AAA AAT GGT GAG CAA GGG CGA G
PLP-1p5’SphI GCA TGC TTG AGC AGA AAA ATT GAG GC
PLP-1p3’KpnI GGT ACC TTC ATT TCG GGC AAA ACT G
Plonp2GFP-F ACG TCA CCG GTT CTA GAT ACT TGA GCA GAA C
unc54-R TAG AGG GTA CCA GAG CTC ACA AAC AGT TAT GG
Pctl-2FSphI GCA TGC ACT TTT GTA TAT AGA ATC TCG
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Table 2.2 continued from previous page
Name Sequence (5’-3’)
Pctl2GFP-F ACG TCA CCG GTT CTA GAT ACA CTT TTG TAT ATA
GAA TCT CGT TAT TTA TAA AC
Pctl2GFP-R TAG AGG GTA CCA GAG CTC ACA AAC AGT TAT GG
Pdaf22-R CTT TAC TCA TTT TTC TGG AAC AAT ATT TTT TTT TC
GFP-unc54-F TTC CAG AAA AAT GAG TAA AGG AGA AGA AC
GFP-unc54-R TTC GAA GAT CTG CCC ACT AGA AAC AGT TAT GTT
TGG TAT ATT G
YFPDHFR-F-KpnI GGT ACC ATG GTG AGC AAG GGC GAG
YFPDHFRPTS-R-
SacI
GAG CTC TTA GAG CTT GGA GTG GAG TGG TCG CCG
CTC CAG AAT CTC
acox-1.6-F ATC ATC GAT GAA TTC GAG CTC ATG AGT CGA TGG
ATT CAG C
acox-1.6-R CTA TAG GGC GAA TTG GGT ACC TTG AAG TGT TGG
AAT AAA CAT AAC
The Pdaf-22mKate2::daf-22 reporter was generated by amplifying the daf-22 pro-
moter from the plasmid pBC1905 using the primers Pdaf22-F and Pdaf22-mKate2-R.
daf-22 and its 3’UTR was amplified from C. elegans genomic DNA using the primers
mKate2-UTR-F and daf22-UTR-R. The primer design for these two constructs was
based on a previously published Pdaf-22GFP::daf-22 construct [Butcher et al., 2009].
The mKate2::linker fragment was amplified from pBC1699 using the primers Pdaf22-
mKate2-F and mKate2-UTR-R. The three PCR products were ligated by Gibson assembly
into the SpeI site of the MiniMos vector pCFJ909 (a gift from Erik Jorgensen; Addgene
plasmid no. 44480), which harbors the cb-unc-119(+) rescue fragment. The obtained
plasmid was named pBC1918. Microinjection of the plasmid pBC1918 (10 ng/µl) into
the strain HT1593(unc-119(ed3)) using MiniMos [Frøkjaer-Jensen et al., 2014] gener-
ated the single-copy insertion allele bcSi117.
30
2.2 GENERATION OF TRANSGENIC ANIMALS
To label the peroxisomal membrane by GFP in cells that express daf-22, a
Pdaf-22GFP::linker::pxmp-4 reporter was generated. To this end, the GFP::linker::pxmp-
4 fusion construct was amplified from the plasmid pBC1577 using the primers
Pdaf22-GFP-F and PXMP4-UTR-R. The PCR product was used to replace the
mKate2::linker::daf-22 fragment of the plasmid pBC1918 by Gibson assembly. Mi-
croinjection of the obtained plasmid pBC1945 (10 ng/μl) into the strain HT1593(unc-
119(ed3)) using MiniMos [Frøkjaer-Jensen et al., 2014] generated the single-copy inser-
tion allele bcSi119. To generate a reporter strain expressing Pdaf-22mKate2::linker::daf-
22 and Pdaf-22GFP::linker::pxmp-4, the strains MD4636(bcSi118) and MD4666(bcSi119)
were crossed.
2.2.2 Reporter to determine the sub-cellular localization of LONP-2
To analyze the sub-cellular localization of LONP-2, Emin Rizovic generated during his
master thesis a Pvha-7GFP::lonp-2 (bcEx1316) reporter, which expresses a GFP::LONP-2
fusion construct in hypodermal cells. To confirm the peroxisomal localization, I crossed
this reporter with the Pvha-7mKate2::pxmp-4 (bcEx1305) reporter, which labels peroxiso-
mal membranes in hypodermal cells, and analyzed male animals of the F1 progeny.
2.2.3 Reporter expressing DHFRmut in peroxisomes
To generate the Pdaf-22YFP::dhfr
mut::PTS1 reporter, the YFP::DHFRmut fusion con-
struct was amplified from the plasmid pBMN YFP-DHFR(DD) (a gift from Thomas
Wandless; Addgene plasmid no. 29326) using the primers YFPDHFR-F-KpnI and
YFPDHFRPTS-R-SacI, which contained the PTS1 (Table 2.2). To generate the plasmid
pBC1635, the obtained PCR product was first cloned into the EcoRV site of pBluescript
KS(+) (Stratagene) and then sub-cloned into the SacI and KpnI sites of pBC970. The
YFP::dhfrmut::PTS1::unc-54 3’ UTR construct was amplified from the plasmid pBC1635
using the primers Pdaf22-DHFR-F and GFP-unc54-R. The daf-22 promoter was ampli-
fied from the plasmid pBC1905 using the primers Pdaf22-F and Pdaf22-DHFR-R. To
generate the plasmid pBC1907, the two PCR products were inserted by Gibson assembly






















2. MATERIALS AND METHODS
plasmid no. 44480), which harbors the cb-unc-119(+) rescue fragment. Microinjection
of the plasmid pBC1907 (10 ng/µl) into the strain HT1593(unc-119(ed3)) using MiniMos
[Frøkjaer-Jensen et al., 2014] generated the single-copy insertion allele bcSi112.
To confirm the peroxisomal localization of the Pdaf-22YFP::dhfr
mut::PTS1 con-
struct, the plasmid pBC1627 (Pvha-7mCherry::PTS1) (5 ng/µl) was injected into the
Pdaf-22YFP::dhfr
mut::PTS1 (bcSi112) reporter. The plasmid pRF4 (80 ng/µl), which con-
tains the rol-6(su1006dm) allele [Mello et al., 1991], was used as a co-injection marker.
The transgenic line bcSi112 carrying the multi-copy extrachromosomal array bcEx1375
was obtained.
2.2.4 Transcriptional reporters to analyze the peroxisomal retrograde signaling
The Plonp-2GFP multi-copy reporters were generated by Stéphane Rolland and me during
my master thesis. Since the reporters are essential for this project, I summarize their
generation in this paragraph. A 1 kb fragment immediately 5’ of the predicted start codon
of lonp-2 was amplified from C. elegans genomic DNA using the primers PLP-1p5’SphI
and PLP-1p3’KpnI (Table 2.2). The fragment was sub-cloned in front of GFP in the
plasmid pPD95 75 (a gift from Andrew Fire; Addgene plasmid no. 1494) to generate the
plasmid pBC1503. Co-injection of the plasmid pBC1503 (5 ng/µl) with pRF4 (80 ng/µl),
which contains the rol-6(su1006dm) allele [Mello et al., 1991], generated a transgenic line
containing the multi-copy extrachromosomal array bcEx1228. The extrachromosomal
array was integrated by UV treatment generating two independent lines (bcIs126 and
bcIs128). Both Plonp-2GFP reporters were back-crossed five times with N2. The insertion
of the bcIs126 allele was mapped by snip-SNP mapping to LGI [Wicks et al., 2001].
To generate the Plonp-2GFP single-copy reporter, the Plonp-2GFP::unc-54 3’UTR con-
struct was amplified from the plasmid pBC1503 using the primers Plonp2GFP-F and
unc54-R. The PCR product was ligated by Gibson assembly into the AvrII site of the
MosSCI vector pCFJ350 (a gift from Erik Jorgensen; Addgene plasmid no. 34866)
[Frøkjaer-Jensen et al., 2012], which harbors the cb-unc-119(+) rescue fragment. Mi-
croinjection of the obtained plasmid pBC1743 (25 ng/µl) into the strain EG8081(oxTi177;
unc-119(ed3)) using MosSCI [Frøkjaer-Jensen et al., 2012] generated the single-copy in-
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sertion allele bcSi75 on LGIV.
To construct the Pctl-2GFP reporter, a 1.6 kb fragment immediately 5’ of the predicted
start codon of ctl-2 was amplified from C. elegans genomic DNA using the primers Pctl-
2FSphI and Pctl-2RAgeI. The lonp-2 promoter of the plasmid pBC1503 was replaced
by the PCR product using the SphI and AgeI restriction sites, generating the plasmid
pBC1690. The Pctl-2GFP fusion construct was amplified from the plasmid pBC1690 with
the primers Pctl2GFP-F and Pctl2GFP-R. Using Gibson assembly, the PCR product was
inserted into the AvrII site of the MosSCI vector pCFJ350 (a gift from Erik Jorgensen;
Addgene plasmid no. 34866) [Frøkjaer-Jensen et al., 2012], which harbors the cb-unc-
119(+) rescue fragment. The obtained plasmid was named pBC1744. Microinjection of
the plasmid pBC1744 (25 ng/µl) into the strain EG8081(oxTi177; unc-119(ed3)) using
MosSCI [Frøkjaer-Jensen et al., 2012] generated the single-copy insertion allele bcSi76
on LGIV.
The Pdaf-22GFP reporter was generated by amplifying a 2.3 kb fragment immedi-
ately 5’ of the predicted start codon of daf-22 from C. elegans genomic DNA using the
primers Pdaf22-F and Pdaf22-R. The GFP::unc-54 3’UTR fusion construct was amplified
from the plasmid pBC1744 using the primers GFP-unc54-F and GFP-unc54-R. The two
PCR products were ligated by Gibson assembly into the SpeI site of the MiniMos vector
pCFJ909 (a gift from Erik Jorgensen; Addgene plasmid no. 44480), which harbors the cb-
unc-119(+) rescue fragment. The obtained plasmid was named pBC1905. Microinjection
of the plasmid pBC1905 (10 ng/µl) into the strain HT1593(unc-119(ed3)) using MiniMos
[Frøkjaer-Jensen et al., 2014] generated the single-copy insertion allele bcSi110.
2.3 Analysis of peroxisomes by fluorescent microscopy
To analyze the tissue-specific localization of peroxisomes and the peroxisomal Lon pro-
tease, young adults of the reporter strains were mounted on 2% agarose pads and im-
mobilized with M9 buffer (Table 2.3) containing 1 mM Levamisol. The slides were
imaged using a Zeiss Axioskop 2 (100x, NA 1.3) equipped with a charge-coupled de-






















2. MATERIALS AND METHODS
vices). For the analysis of peroxisomes in hypodermal cells, the Pvha-7GFP::PTS1
and Pvha-7mKate2::pxmp-4 reporter strain was imaged with the alae in focus and
1000 ms exposure time using a GFP and mCherry filter, respectively. To analyze the
sub-cellular localization of LONP-2 in hypodermal cells, the Pvha-7lonp-2::GFP and
Pvha-7mKate2::pxmp-4 reporter strain was analyzed under the same conditions. To an-
alyze the sub-cellular localization of DAF-22, the Pdaf-22mKate2::daf-22 reporter was
imaged with 100 ms exposure time using a mCherry filter. Single plane images of the
anterior part of the intestine (nuclei in focus) or of the head (hypodermal and head muscle
cells in focus) were taken. To analyze the sub-cellular localization of the peroxisomal
Lon protease, single plane images of the Pvha-7GFP::lonp-2 and Pvha-7mKate2::pxmp-4
reporter strain were taken with 1000 ms exposure time using a GFP and mCherry filter,
respectively.
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2.4 RNA interference experiments
The bacterial clones for RNAi by feeding were obtained from the Ahringer library [Ka-
math and Ahringer, 2003]. The acox-1.1(RNAi) clone was taken from the Vidal library
[Rual et al., 2004] and the tag-208(RNAi) clone was previously generated in the labo-
ratory [Rolland et al., 2019]. The control mock(RNAi) contains HT115 RNAi bacteria
transformed with the empty RNAi vector pPD129.36. The acox-1.6(RNAi) clone was
generated by amplifying the first three exons of acox-1.6 from genomic DNA using the
primers acox-1.6-F and acox-1.6-R (Table 2.2). The PCR product was ligated into the
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SacI and KpnI site of pPD129.36 (a gift from Andrew Fire; Addgene plasmid no. 1654)
by Gibson assembly and the obtained plasmid was transformed into HT115 RNAi bacte-
ria.
On day one, the RNAi clones were inoculated into 2 ml of LB carbenicillin
(100 µg/ml) tetracycline (12.5 µg/ml) (Table 2.4) and cultured overnight at 37◦C and
200 rpm. The next day, 2 ml of LB carbenicillin (100 µg/ml) was inoculated with 20 µl
of the overnight culture and was grown at 37◦C and 200 rpm for 6 h. The RNAi cultures
were then adjusted to 0.5 OD and 50 µl was used to seed a first set of 30 mm RNAi plates
containing 6 mM IPTG [Rolland et al., 2019]. In the case of double RNAi experiments,
each RNAi culture was diluted 1:2 (vol/vol). After seeding, the plates were protected from
light and incubated at room temperature until the next day. On day three, a second set of
RNAi plates were seeded (following the same protocol as for the first set of RNAi plates).
Furthermore, four to eight L4 larvae of the transcriptional reporter strains were inoculated
onto the seeded RNAi plates and incubated at 20◦C for 22 h. During this incubation, the
L4 larvae developed into adults and were transferred onto the second set of RNAi plates.
The adults were let to lay eggs for 4 h at 20◦C and then removed (hereafter referred to as
’lay-off’). The synchronized progeny was incubated for three days at 20◦C. For imaging,
about 10-15 F1 gravid adults per RNAi condition were mounted on 2% agarose pads and
immobilized with M9 buffer containing 1 mM Levamisol. The slides were imaged using a
Leica GFP dissecting microscope (M205 FA, Planapo 1× objective, 35x zoom, NA 0.07)
with a GFP filter and the software Leica Application Suite (3.2.0.9652). The exposure
time was set to 200 ms for all images to be able to compare the different fluorescence
intensities.
In the case of the RNAi experiment to analyze peroxisomal import (see chapters 3.1.3,
3.1.4), the population was not synchronized by a lay-off. Instead, the stage of the F1
animals was determined by DIC microscopy and only young adults carrying not more than
three eggs were mounted on 2% agarose pads and immobilized with M9 buffer containing
1 mM Levamisol. The anterior part of the intestine (nuclei in focus) or the hypodermis
of the same region (alae in focus) of the Pdaf-22mKate2::daf-22 and Pdaf-22GFP::pxmp-


























Yeast extract 5.0 g
NaCl 10.0 g
MilliQ H2O 0.8 l
Lambda Blue 63x oil objective, NA 1.4, 488 nm and 561 nm lasers) and the LAS AF
software (Leica). At the anterior part of the Pvha-7GFP::PTS1 and Pvha-7mKate2::pxmp-4
reporter strain, the hypodermal cells were imaged with the alae in focus with 1000 ms
exposure time and GFP and mCherry filters using a Zeiss Axioskop 2 (100x, NA 1.3)
equipped with a charge-coupled device camera (1300; Micromax) and the MetaMorph
software 7.1.0.0 (Molecular Devices).
The RNAi by feeding protocol was also modified for the preparation of the samples for
the proteomic analysis (see chapter 3.3.10). On day one, the RNAi clones were streaked
out on LB carbenicillin (100 µg/ml) tetracycline (12.5 µg/ml) plates and the plates were
incubated overnight at 37◦C. On day two, the RNAi bacteria were resuspended in LB
and a first set of 100 mm RNAi plates containing 6 mM IPTG (two plates per condition)
were seeded with 600 µl of RNAi suspension OD 0.5. In order to reduce the slow-growth
phenotype, the prx-5(RNAi) and prx-19(RNAi) cultures were diluted 1:2 (vol/vol) with
mock(RNAi). After seeding, the plates were protected from light and incubated at room
temperature until the next day. On day three, a second set of RNAi plates were seeded
(following the same protocol as for the first set of RNAi plates). Furthermore, ∼200 N2
L4 larvae were pipetted onto each RNAi plate that was seeded the previous day. After
incubation at 20◦C for 22 h, the gravid adults were pipetted onto the second set of RNAi
plates, let to lay eggs for four hours at 20◦C and then removed. The synchronized progeny
was incubated for three days (mock(RNAi) and tag-208(RNAi)) or four days (prx-5(RNAi)
and prx-19(RNAi)) at 20◦C to reach the adult stage and then collected in a tube. The worm
pellet was washed four times with 10 ml of 1x PBS (Table 2.5). The samples were flash
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frozen in liquid nitrogen and stored at -80◦C until they were analyzed by LC-MS (see
chapter 2.9).
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I developed a large scale protocol for the the preparation of the samples for the RNA-
seq analysis (see chapter 3.3.9). The samples for the analysis were prepared by Judith
Zacherl. On day one, the RNAi clones were inoculated into 2 ml of LB carbenicillin
(100 µg/ml) tetracycline (12.5 µg/ml) and cultured overnight at 37◦C and 200 rpm. The
next day, 2 ml of LB carbenicillin (100 µg/ml) was inoculated with 20 µl of the overnight
culture and was grown at 37◦C and 200 rpm for 6 h. The RNAi cultures were then adjusted
to 0.5 OD and 600 µl was used to seed a first set of 100 mm RNAi plates containing
6 mM IPTG (2 plates per condition). In order to reduce the slow-growth phenotype, the
prx-5(RNAi) culture was diluted 1:2 (vol/vol) with mock(RNAi). After seeding, the plates
were protected from light and incubated at room temperature until the next day. On day
three, a second set of RNAi plates (8 large plates per condition) were seeded following the
same protocol as for the first set of RNAi plates. Furthermore, ∼160 N2 L4 larvae were
pipetted onto each RNAi plate that was seeded the previous day. After incubation at 20◦C
for 22 h, the gravid adults were pipetted onto the second set of RNAi plates, let to lay
eggs for 2 hours at 20◦C and then removed. The synchronized progeny was incubated for
three days (mock(RNAi) and tag-208(RNAi)) or four days (prx-5(RNAi)) at 20◦C to reach
the adult stage and then collected in a tube. The worm pellet was first washed with 50 ml
MPEG (M9 + 0.1% Polyethylene glycol 8000 (Carl Roth)). The pellet was transferred
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M9. The samples were flash frozen in liquid nitrogen and stored at -80◦C until they were
analyzed by RNA-seq (see chapter 2.8).
2.5 Trimethoprim treatment
Trimethoprim (TMP) plates (30 mm) were prepared by adding TMP (Sigma) (100 mM in
DMSO stock solution) to standard NGM media [Stiernagle, 2006] that was autoclaved
and had cooled down to 55°C. The final concentration of TMP or DMSO (for control
plates) was 1 mM. The plates were let to dry overnight at room temperature. E. coli OP50
was cultured in 4 ml LB overnight at 37◦C and 200 rpm. The culture was pelleted and
resuspended in 400 µl LB. The plates were seeded with 50 µl OP50 culture and let to dry
for 30 min.
To analyze the effect of the knock-down of lonp-2 (see chapter 3.2.2), the RNAi pro-
tocol (see chapter 2.4) was modified. The L4 larvae were not treated by RNAi, but adults
that were grown on NGM plates were transferred onto RNAi plates and let to lay eggs
for 4 h at 20◦C and then removed. The synchronized progeny was incubated for four
days at 15◦C. The L4 larvae were then transferred onto NGM plates containing TMP or
DMSO and incubated for 24 h at 20◦C. The worms were mounted on 2% agarose pads
and immobilized with M9 buffer containing 1 mM Levamisol. The anterior part of the in-
testine (nuclei in focus) or the hypodermis (alae in focus) of the same region were imaged
using a Zeiss Axioskop 2 (100x, NA 1.3) equipped with a charge-coupled device cam-
era (1300; Micromax) and the MetaMorph software 7.1.0.0 (Molecular Devices). The
Pdaf-22YFP::dhfr
mut::PTS1 reporter was imaged with a YFP filter and 1000 ms exposure
time and and Pvha-7mCherry::PTS1 reporter was imaged with a mCherry filter and 200 ms
exposure time. Furthermore, samples were collected for Western analysis (see chapter
2.6).
For the time course experiment (see chapter 3.2.3), transgenic animals expressing
DHFRmut were synchronized by lay-off (4 h at 20◦C). L4 larvae were placed on the plates
containing TMP or DMSO and incubated at 20◦C. After 6 h and 24 h of treatment, the
worms were mounted on 2% agarose pads and immobilized with M9 buffer containing
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1 mM Levamisol. The hypodermal cells of the anterior part of the worms were imaged
with the alae in focus with a YFP filter and 1000 ms exposure time using a Zeiss Axioskop
2 (100x, NA 1.3) equipped with a charge-coupled device camera (1300; Micromax) and
the MetaMorph software 7.1.0.0 (Molecular Devices). After 24 h of treatment with TMP,
the worms were transferred onto DMSO plates. 3 h and 6 h after the start of the washout
period, they were again imaged and collected for Western analysis.
2.6 Analysis of protein levels by Western blotting
Synchronized C. elegans adult populations were either obtained by lay-offs or L4 larvae
were picked onto a new NGM plate seeded with E. coli OP50 and incubated at 20◦C for
one day. The population was collected in a tube and washed three times with 1 ml MPEG.
The C. elegans pellet was resuspended in 1 volume of Laemmli buffer 2x (Table 2.6). The
samples were incubated for 5 min at 95◦C and stored at -20°C.
Table 2.6: Laemmli Buffer (2x).
Component Amount
Tris 0.12 g
HCl (1 M) 0.77 ml (to pH 6.8)
SDS 8.00 mg
MilliQ H2O 1.23 ml
10% SDS 4.00 ml
Beta-Mercaptoethanol 0.14 ml
50% Glycerol 4.00 ml
Saturated Bromophenol blue 0.10 ml
The samples were centrifuged at 13,000 rpm for 1 min and the supernatant was used
for SDS-PAGE (10% acrylamide). After separation by electrophoresis, the proteins were
transferred to a PVDF membrane (Immobilon-P, Millipore). The membrane was blocked
using 5% milk powder in TBS-T (Table 2.7) for 1 h at room temperature. The mem-
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ondary antibodies for 45 min at room temperature. To detect Tubulin, monoclonal anti-
Tubulin (1:10,000; Sigma) and horseradish peroxidase conjugated goat anti-mouse an-
tibodies (1:7,500; BioRad #1706516) were used. HSP-6 was detected by a polyclonal
anti-HSP-6 (1:5,000; [Köhler et al., 2015]) and horseradish peroxidase conjugated goat
anti-rabbit antibodies (1:30,000; BioRad #1706515). To detect GFP, polyclonal anti-GFP
(1:6,000; abcam ab290) and GAR-HRP antibodies (1:10,000) were used. The rabbit
polyclonal anti-LONP-2 antibodies were generated using the antigenic peptide CDKFS-
REIYSLIDEKEYGKLAD (LONP-2 C-terminal sequence) and subsequently affinity pu-
rified by Davids Biotechnologie and used at 1:3,000 for Western analysis. As secondary
antibodies, horseradish peroxidase conjugated goat anti-rabbit antibodies (1:5,000; Bio-
Rad #1706515) were used. The chemiluminescence was detected using the Amersham
ECL (Prime) Western Blotting Detection Reagent (GE Healthcare) and the Chemi Doc







HCl adjust pH to 7.4
Tween 100 (Carl Roth) 0.1 ml
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2.7 Lipid staining by Oil Red O
Lipid staining using the fixative dye Oil Red O (Sigma) was conducted as previously de-
scribed [Escorcia et al., 2018]. Briefly, L4 larvae were picked onto a new NGM plate
seeded with E. coli OP50 and incubated at 20◦C for one day. The Oil Red O stock so-
lution (500 mg/100 ml isopropanol) was diluted in water to 60% isopropanol and rocked
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overnight. The next day, the worms were collected in a tube and washed three times with
1 ml PBST (1x PBS + 0.01% Triton X-100). The supernatant was removed, 600 µl of
40% isopropanol was added to the worm pellet and it was rocked for 3 min. The worms
were centrifuged and the supernatant was removed. The Oil Red O working solution was
filtered with a 22 µm PVDF filter and 600 µl of the filtered Oil Red O solution was added
to the worm pellet. The samples were rocked for 2 h. The dye was removed and the worm
pellet was resuspended in 600 µl PBST and rocked for 30 min to remove excess dye. The
PBST was removed, the worms were resuspended in the remaining supernatant and were
mounted on a microscope slide. The samples were imaged with 60 ms exposure time us-
ing a Leica MZ FLIII microscope (10x, NA 0.125) with a color-capable Nikon Digital
Sight DS-Fi1 camera and the software NIS-Elements BR 3.10.
2.8 Gene expression analysis by RNA-seq
The frozen worm pellets of the RNAi experiment (see chapter 2.4) were send to Eu-
rofins Genomics Europe Shared Services GmbH. Total RNA was extracted by the com-
pany using commercial kits with modified and optimized protocols. The library was pre-
pared with an optimized protocol and standard Illumina adapter sequences have been
used. Sequencing was performed with Illumina technology, HiSeq 4000 (read mode 1 x
50bp). The bioinformatics analysis by the company included the alignment of the RNA-
Seq reads to the reference genome using Bowtie [Langmead et al., 2009]. Cufflinks,
Cuffmerge and Cuffdiff was used to determine the differential expression levels. Genes
were considered as significantly changed if the p-value was greater than the FDR af-
ter Benjamini-Hochberg correction for multiple testing. The data has been deposited in
NCBI’s Gene Expression Omnibus [Edgar et al., 2002] and is accessible through GEO
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2.9 Protein quantification by LC-MS
The worm pellets of the RNAi experiment (see chapter 2.4) were treated by an initial step
of sonication with glass beads (Bioruptor, Diagenode) and subsequently proteins were ex-
tracted and digested using the iST Preomics Kit (Germany). The analysis by LC-MS was
conducted by our collaborator Ignasi Forné (Axel Imhoff lab; BMC Munich). The sam-
ples were injected in an RSLCnano system (Thermo) and separated in a 25-cm analytical
Aurora C18 nanocolumn (75μm ID 120 Å, 1.6 μm, Ion Opticks). The effluent was directly
electrosprayed into a Q Exactive HF (Thermo). MaxQuant 1.5.2.8 was used to identify
proteins and quantify by LFQ. If the log2 value was >1 or <-1 and the p-value was <
0.05 in a limma moderated t-test adjusted for multiple comparisons when compared to
the control tag-208(RNAi), the level of the identified protein was considered as signifi-
cantly changed. The data set has been deposited to the ProteomeXchange Consortium
via the PRIDE [Perez-Riverol et al., 2019] partner repository with the dataset identifier
PXD014720.
2.10 Image analysis
The image analysis of the transcriptional reporter strains was performed as previously
described [Rolland et al., 2019]. For the analysis of the peroxisomal number (see chap-
ter 3.1.4) and the Oil Red O staining (see chapter 3.3.6), two-dimensional images were
analyzed using Fiji/ImageJ2 [Rueden et al., 2017, Schindelin et al., 2012] with Fiji-
implemented macros using the IJ1 Macro language, which were programmed by Christian
Fischer (Barabra Conradt lab; LMU Munich).
To analyze the peroxisomal number, signal intensity and surface, the background of
the fluorescent images was subtracted with a rolling ball radius and a binary mask of the
image was generated using the Otsu automated threshold. Next, noise was removed by
applying the Particle Analyzer with a minimum size of four pixels to the inverted mask.
The original image was multiplied with the mask and the number of peroxisomes was
measured by the 3D Objects counter plug-in for ImageJ.
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The macro to analyze the Oil Red O staining was based on the image quantification
performed by O’Rourke et al. [O’Rourke et al., 2009]. However, to improve the accuracy
of the IsoData autothresholding to generate the whole worm mask, a maximum filter of
five pixels was applied prior to top-hat filtering.
2.11 Statistical analysis
Statistical analysis was performed using the software R version 3.6.1 [R Core Team, 2019]
with the packages Rmisc [Hope, Ryan M., 2013], car [Fox, John and Weisberg, San-
ford, 2019], userfriendlyscience [Peters, Gjalt-Jorn Ygram, 2017] and PMCMR [Pohlert,
Thorsten, 2014]. Normal distribution of the data was analyzed by diagnostic plots and
additionally by a Shapiro-Wilk test. If two independent groups were compared, an F-test
was used to test for equal variance. In the case of normal distribution and equal vari-
ance, a two sample t-test was applied to compare two independent groups. In the case of
not normally distributed data, a Mann-Whitney-U test was used and in the case of het-
eroscedasticity, a Welch two sample t-test was used. If more than two independent groups
were compared, a Brown-Forsythe test was used to test for equal variance. Data show-
ing a normal distribution and equal variance was analyzed using a one-way ANOVA with
Tukey’s multiple comparison. Non-parametric data was analyzed using a Kruskal-Wallis
test with Dunns’s multiple comparison and Holm’s p-value adjustment. In the case of



























3.1 Analysis of peroxisomes in C. elegans by fluorescent microscopy
3.1.1 Peroxisomes are present in hypodermal cells in C. elegans
Previous studies have shown that peroxisomes are mostly present in hypodermal and in-
testinal cells in C. elegans [Yokota et al., 2002, Petriv et al., 2002]. To confirm the hypo-
dermal localization of peroxisomes, I generated a reporter strain expressing GFP fused to
the tripeptide SKL, which acts as a peroxisomal targeting sequence (PTS1) in C. elegans
[Petriv et al., 2002]. The GFP::PTS1 fusion construct labels the peroxisomal matrix with
GFP. Furthermore, the strain expressed the fusion construct mKate2::PXMP-4 to label
the peroxisomal membrane with mKate2. The mammalian homolog of PXMP-4 has been
shown to localize to the peroxisomal membrane [Pinto et al., 2006]. The constructs were
placed under the control of the vha-7 promoter, which is expressed in hypodermal cells.
Fluorescent microscopy analysis of adult animals of the reporter strain showed a punctate
signal in both channels, which is characteristic of peroxisomes (Figure 3.1). This also
shows that PXMP-4 localizes to peroxisomes like its mammalian homolog. The GFP and
mKate2 signals mostly co-localized. However, sometimes the peroxisomes were only la-
beled by mKate2, but not by GFP (Figure 3.1, arrowheads). These peroxisomes might
represent pre-peroxisomes that are not yet import competent. Taken together, I confirmed







Figure 3.1: Labeling of peroxisomes in hypodermal cells. Analysis of adult animals carrying
the Pvha-7GFP::PTS1 and Pvha-7mKate2::pxmp-4 (bcIs140) reporters by DIC and fluorescent mi-
croscopy. Arrowheads show peroxisomes only labeled by mKate2 and not by GFP. The scale bar
represents 10 µm.
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3.1.2 The peroxisomal matrix protein DAF-22 localizes to hypodermal cells and the
intestine
To determine the tissue-specific localization of peroxisomes, I generated a reporter ex-
pressing the peroxisomal matrix protein DAF-22 fused to mKate2 under its endogenous
promoter and 3’UTR. A similar construct has previously been used to label peroxisomes
[Butcher et al., 2009]. Analysis of adult animals of the Pdaf-22mKate2::daf-22 (bcSi117)
reporter by fluorescent microscopy revealed that peroxisomes that contain DAF-22 were
mainly present in hypodermal and intestinal cells (Figure 3.2). This confirms the results of
the analysis of the Pvha-7GFP::PTS1 and Pvha-7mKate2::pxmp-4 (bcIs140) reporter (Fig-
ure 3.1) and the observations made in previous studies [Yokota et al., 2002, Petriv et al.,
2002, Butcher et al., 2007]. The number of peroxisomes was higher in the intestine than
in hypodermal cells (Figure 3.2). In both tissues, the peroxisomes showed some variation
in size and signal intensity. Interestingly, in head muscle cells, only very few peroxisomes
with weak signal intensity were present (Figure 3.2, arrowhead). Due to the expression
of the reporter in the hypodermal cells, it was not possible to determine if middle body
muscle cells also contain peroxisomes. Similarly, it was difficult to determine the exact
location of the neurons. However, it seems that head neurons do not contain peroxisomes.
To label the different tissues by a fluorescent marker would help to identify the right tis-
sue and thus could give a more reliable result. The results suggest that, like previously
reported, peroxisomes are mostly present in the intestinal and hypodermal cells of C. ele-
gans adult animals.
3.1.3 Knock-down of prx-5 leads to a reduction of peroxisomal matrix protein im-
port in the intestine
PRX-5 is required for the import of peroxisomal matrix proteins [Petriv et al., 2002]. To
examine the effect of the knock-down of prx-5 on peroxisomal matrix protein import,
I generated a reporter strain expressing mKate2::DAF-22 and GFP::PXMP-4 under the
control of the daf-22 promoter (Figure 3.3A). L4 larvae carrying the Pdaf-22mKate2::daf-





















Figure 3.2: Tissue-specific localization of the peroxisomal matrix protein DAF-22. Analysis of
adult animals carrying the Pdaf-22mKate2::daf-22 (bcSi117) reporter by DIC and fluorescent mi-
croscopy. In the left schematic, hypodermal cells are highlighted with dots and muscle cells in
grey. Both cell types are present in the same microscopy image. The arrowhead points at a perox-
isome in a muscle cell. In the right schematic, the intestine is highlighted in grey. The different
intensity values (Min and Max) are indicated and the scale bar represents 10 µm.
trol tag-208(RNAi), which encodes the C. elegans homolog of human Sorbin. To reduce
the slow-growth phenotype, prx-5(RNAi) was diluted with tag-208(RNAi), which results
in a ∼60% reduction of PRX-5 protein (see proteomic analysis in chapter 3.3.10). The
adults of the next generation were analyzed by confocal microscopy. In intestinal cells,
the knock-down of prx-5 led in the majority of analyzed animals (77%) to a partial block
of the import of mKate2::DAF-22 (Figure 3.3B, C). The remaining animals either showed
a complete block of import (14%) or the import was not affected (9%). In contrast,
in hypodermal cells, the import of mKate2::DAF-22 was not affected by prx-5(RNAi)
(Figure 3.3C). However, qualitative analysis of the images suggested that the number of
membrane-labeled peroxisomes was higher under prx-5(RNAi) conditions compared to
tag-208(RNAi). Since the expression of the reporter in hypodermal cells was weak, it was
not possible to analyze this effect quantitatively. To summarize, the partial knock-down
of prx-5 leads to a reduction in peroxisomal matrix protein import in the intestine.
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Figure 3.3: Knock-down of prx-5 leads to a reduction of peroxisomal matrix protein import in
the intestine. (A) Schematic representation of the Pdaf-22mKate2::daf-22 and Pdaf-22GFP::pxmp-
4 reporters. (B) L4 larvae carrying the Pdaf-22mKate2::daf-22 and Pdaf-22GFP::pxmp-4 reporters
were subjected to tag-208(RNAi) or prx-5(RNAi) and adults of the next generation were analyzed
by confocal microscopy. The prx-5(RNAi) was diluted 1:2 with tag-208(RNAi) to reduce the slow
growth phenotype. Semi-quantitative analysis of the mKate2::DAF-22 import upon prx-5(RNAi)
in intestinal cells. (n=22 (n=number of animals analyzed in 3 independent experiments)). (C) Rep-
resentative images of the experiment. The scale bar represents 10 µm and 5 µm in the enlarged
images. For the intestinal cells, representative images of a partial block of mKate2::DAF-22 im-












3.1.4 Reduced peroxisomal biogenesis induces an increase in the peroxisomal num-
ber in the hypodermis
To quantify the the effect of prx-5(RNAi) on the peroxisomal number in hypodermal cells,
I used the Pvha-7GFP::PTS1 and Pvha-7mKate2::pxmp-4 (bcIs140) multi-copy reporter
strain (see chapter 3.1.1). Additionally to prx-5(RNAi), the effect of the knock-down
of prx-19 on peroxisomal number was analyzed. prx-19 encodes a homolog of the hu-
man receptor for peroxisomal membrane protein insertion PEX19 [Petriv et al., 2002].
L4 larvae carrying the Pvha-7GFP::PTS1 and Pvha-7mKate2::pxmp-4 (bcIs140) reporters
were subjected to the different RNAi and adults of the next generation were analyzed by
fluorescence microscopy. The fluorescence intensity, size and number of peroxisomes
in the images was quantified in the GFP and mKate2 channel using a Fiji-implemented
macro. The negative control tag-208(RNAi) showed the same number of GFP::PTS1 or
mKate2::PXMP-4 labeled peroxisomes as the negative control mock (RNAi bacteria car-
rying the empty vector L4440) (Figure 3.4B). Knock-down of prx-5 and prx-19 did not
lead to a significant change in the number of GFP::PTS1 labeled peroxisomes compared
to tag-208(RNAi) (Figure 3.4A,C). In contrast, the number of peroxisomes labeled by
mKate2::PXMP-4 increased about 1.5-fold compared to the control. Thus, about one
third of the peroxisomes detected in the mKate2 channel did not import GFP::PTS1.
Activation of the mammalian PPARα leads to increased peroxisome proliferation
[Reddy and Chu, 1996]. In C. elegans, the nuclear hormone receptor NHR-49 is a func-
tional homolog of PPARα [Gilst et al., 2005]. Therefore, we asked if NHR-49 is required
for the increase in peroxisomal abundance upon knock-down of prx-5. A double RNAi ex-
periment showed that prx-5(RNAi) led to an increase in mKate2::PXMP-4 labeled peroxi-
somes, whereas the additional knock-down of nhr-49 suppressed the response and the per-
oxisomal number was similar to the control tag-208(RNAi) (Figure 3.4D). Furthermore, I
observed that a knock-down of nhr-49 in the control (nhr-49(RNAi) + tag-208(RNAi)) led
to a decrease in the number of peroxisomes labeled with mKate2::PXMP-4. This suggests
that the peroxisomal number is dependent on NHR-49.
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Figure 3.4: Perturbation of peroxisomal biogenesis leads to an increase in peroxisomal abun-
dance, which is dependent on the transcription factor NHR-49. (A) L4 larvae carrying the
Pvha-7GFP::PTS1 and Pvha-7mKate2::pxmp-4 (bcIs140) reporters were subjected to different
RNAi. The RNAi clones were diluted 1:2 with tag-208(RNAi) to reduce the slow growth phe-
notype. Adults of the next generation were analyzed by DIC and fluorescent microscopy. The
scale bar represents 10 µm. (B) The number of peroxisomes per image of the two controls mock
and tag-208(RNAi) was quantified in the GFP or mKate2 channel (n=11-16 (n=total number of
animals analyzed from 3 independent experiments); mean and SD are shown; n.s.=not significant
by a two sample t-test). (C) The number of peroxisomes per image was quantified in the GFP or
mKate2 channel (n=13-20 (n=total number of animals analyzed from 3 independent experiments);
mean and SD are shown; n.s.=not significant and ** p<0.01 by a Kruskal-Wallis test with Dunn’s
post hoc test). (D) Dependence of the peroxisomal abundance on NHR-49. The RNAi clones
were diluted 1:2 with the RNAi clone indicated in the x-axis label. (n=18 (n=total number of
animals analyzed from 3 independent experiments); mean and SD are shown; n.s.=not significant,












Next, I analyzed the effect of knock-down of prx-5 and prx-19 on the fluorescence
intensity and peroxisome size. Knock-down of both peroxins led to a slight increase in
the fluorescence intensity of the GFP::PTS1 labeled peroxisomes (Figure 3.5A). This sug-
gests that some peroxisomes might have an increased import to compensate for the non-
functional peroxisomes. The median of the measured mKate2 fluorescence intensities
was similar in all three RNAi conditions. However, upon prx-19(RNAi), the proportion
of peroxisomes with weak mKate2 signal was higher than in the control tag-208(RNAi).
Knock-down of both peroxins did not change the distribution of the size of the peroxi-
somes measured in both channels (Figure 3.5B). Taken together, a perturbation of per-
oxisomal biogenesis leads to an increase in peroxisomal abundance. However, not all
peroxisomes are import competent. Furthermore, upon reduction of the receptor PRX-19,
































































































Figure 3.5: Perturbation of peroxisomal biogenesis affects the import of GFP::PTS1 and the inser-
tion of mKate2::PXMP-4. The images of the experiment shown in Figure 3.4 were analyzed for an
effect on peroxisomal fluorescence intensity and size. (A) The violin plot shows the distribution of
the fluorescence intensity of the peroxisomes quantified in the GFP or mKate2 channel. The white
dot represents the median. (n=1713-4465 (n=total number of peroxisomes analyzed from 3 inde-
pendent experiments)). (B) The violin plot shows the distribution of the size of the peroxisomes
quantified in the GFP or mKate2 channel. The white dot represents the median. (n=1713-4465
(n=total number of peroxisomes analyzed from 3 independent experiments)).
3.1.5 The prx-5(tm4948) loss of function mutation causes a block in peroxisomal
matrix protein import and affects peroxisomal morphology
To test the effect of the loss of the import receptor PRX-5 on peroxisomal biogene-
sis, I crossed the prx-5(tm4948) loss of function allele into the Pvha-7GFP::PTS1 and
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Pvha-7mKate2::pxmp-4 (bcIs140) reporter strain. The prx-5(tm4948) allele is a 437 bp
deletion that affects the first two exons of prx-5. Upon loss of PRX-5, the import of
GFP::PTS1 was impaired and the animals showed a cytosolic GFP signal (Figure 3.6).
The animals carrying the prx-5(tm4948) mutation showed two different phenotypes in the
mKate2 channel. Either the peroxisomes were very large and showed high mKate2 inten-
sity or their size was similar to wild-type but some of the peroxisomes were elongated.
Taken together, a loss of matrix protein import induces changes in peroxisomal morphol-
ogy. In contrast, a mild reduction of peroxisomal matrix protein import by RNAi leads to





























Figure 3.6: The prx-5(tm4948) loss of function mutation affects peroxisomal morphology. The
Pvha-7GFP::PTS1 and Pvha-7mKate2::pxmp-4 (bcIs140) reporter carrying the prx-5(tm4948) mu-
tation was analyzed by DIC and fluorescence microscopy. Representative images of two different
phenotypes are shown. The scale bar represents 10 µm. (n=2 (n=number of independent experi-
ments)).
3.2 Characterization of the peroxisomal Lon protease in C. elegans
3.2.1 The peroxisomal Lon protease homolog LONP-2 is targeted to peroxisomes
The C. elegans protein LONP-2 shows 35.3% identity and 65.9% similarity to the hu-
man peroxisomal Lon protease (LALIGN; [Huang and Miller, 1991]). LONP-2 has an












proteolytic domain (InterPro) (Figure 3.7A). Furthermore, it has a C-terminal putative
peroxisomal targeting sequence AKL. To confirm that LONP-2 localizes to peroxisomes
in C. elegans, I generated a reporter strain co-expressing LONP-2 tagged with GFP at
the N-terminus and a peroxisomal membrane marker mKate2::PXMP-4 in hypodermal
cells. Analysis of the reporter strain by fluorescent microscopy showed that the GFP
and mKate2 signals co-localized (Figure 3.7B). This indicates that LONP-2 is targeted to
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Figure 3.7: Sub-cellular localization of the C. elegans peroxisomal Lon protease LONP-2. (A)
Predicted functional domains of LONP-2 (InterPro). The numbers represent the amino acids. (B)
Analysis of the Pvha-7mKate2::pxmp-4 and Pvha-7GFP::lonp-2 (bcEx1305;bcEx1316) reporter by
DIC and fluorescent microscopy. The scale bar represents 20 µm (top panels) or 5 µm in the
enlarged images (bottom panels).
3.2.2 The degradation of an unfolded protein is dependent on the peroxisomal Lon
protease
The peroxisomal Lon protease degrades non-functional proteins in yeast and fungi [Bar-
toszewska et al., 2012, Aksam et al., 2007]. Furthermore, it shows chaperone activity in
vitro [Bartoszewska et al., 2012]. The function of the peroxisomal Lon protease in C. ele-
gans has not been described so far. To express an unfolded protein in peroxisomes, I used
a mutant form of the E. coli dihydrofolate reductase (DHFRmut), which is without binding
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of a stabilizing ligand constitutively degraded by the 26S proteasome. Upon addition of
the ligand Trimethoprim (TMP), DHFRmut is stabilized [Cho et al., 2013]. By fusion of
DHFRmut to YFP, the stability of the protein can be monitored by fluorescence microscopy
and Western blotting. To target YFP::DHFRmut to peroxisomes, a C-terminal peroxisomal
targeting sequence (PTS1) was added (Figure 3.8A). The YFP::DHFRmut::PTS1 was ex-
pressed under the control of the promotor of the peroxisomal thiolase daf-22. To confirm
the peroxisomal localization, I injected a reporter to label the hypodermal peroxisomes
(Pvha-7mCherry::PTS1) into the Pdaf-22YFP::dhfr
mut::PTS1 (bcSi112) strain. Upon treat-
ment of the resulting reporter strain with TMP (1 mM in DMSO) for 24 h, the construct
was stabilized and the YFP signal intensity strongly increased compared to the DMSO
control (Figure 3.8B). The co-localization of the YFP signal with the mCherry signal
confirms that YFP::DHFRmut::PTS1 is targeted to peroxisomes.
To test if the degradation of DHFRmut is dependent on the peroxisomal Lon protease,
the Pdaf-22YFP::dhfr
mut::PTS1 (bcSi112) reporter strain was treated with lonp-2(RNAi)
or the negative control mock for one generation. The L4 larvae were then transferred
onto TMP or DMSO control plates. After 24 h of incubation, whole worm lysates were
analyzed by Western blotting. The analysis showed that the knock-down of lonp-2 was
efficient (Figure 3.9A). Upon lonp-2(RNAi), the LONP-2 band completely disappeared.
Hardly any YFP signal was visible in the samples of animals that were grown on mock and
DMSO plates (Figure 3.9A). In contrast, treatment by mock and TMP led to a stabilization
of DHFRmut and thus to an increase in the YFP signal. Interestingly, also the knock-down
of lonp-2 led to a strong increase in the YFP signal in animals grown on DMSO plates.
This indicates that LONP-2 is required for the degradation of destabilized DHFRmut in
peroxisomes. Although DHFRmut is stabilized by TMP treatment, a further increase in
YFP signal upon lonp-2(RNAi) could be observed. It is possible that the stabilization by
TMP is not complete and that there is still a fraction of unfolded DHFRmut that is imported
into peroxisomes and is degraded by LONP-2. Another possibility is that LONP-2 is
involved in the degradation of proteins that are mislocalized to peroxisomes.
To get an insight about the sub-cellular localization of the accumulated YFP, the







































Figure 3.8: Reporter to express an unfolded protein in peroxisomes. (A) Schematic of the sta-
bilization of DHFRmut by Trimethoprim (TMP). DHFRmut is fused to a peroxisomal targeting
sequence (PTS1). In the absence of the stabilizing ligand, the construct is degraded by the pro-
teasome. Upon addition of TMP, the construct is stabilized and localizes to peroxisomes. (B)
YFP::DHFRmut::PTS1 localizes to peroxisomes. Three independent lines carrying the reporter
Pdaf-22YFP::dhfr
mut::PTS1 and Pvha-7mCherry::PTS1 (bcSi112;bcEx1375) were treated for 24 h
by TMP or DMSO control and were analyzed by DIC and fluorescent microscopy. Representative
images of one line are shown. The scale bar represents 10 µm.
of the intestine of 15 animals per condition were taken. Moreover, the peroxisomes in the
hypodermis of the same region of the animal were imaged, since they are more suitable
for quantitative analysis. The intestinal peroxisomes showed an overall increase in YFP
signal upon lonp-2(RNAi) or TMP treatment, similar to the result of the Western analysis
(Figure 3.9B). Upon knock-down of lonp-2, some peroxisomes showed a very strong YFP
signal. The qualitative observation was confirmed by the quantitative analysis of the hypo-
dermal peroxisomes. The total number of peroxisomes and the fluorescence intensity per
peroxisome was quantified by an Fiji-implemented macro. The overall signal intensity per
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Figure 3.9: Dependence of the degradation of DHFRmut on LONP-2. The
Pdaf-22YFP::dhfr
mut::PTS1 (bcSi112) reporter was treated with mock (empty vector control)
or lonp-2(RNAi) for one generation and then L4 larvae were transferred onto TMP or DMSO
control plates. After 24 h of incubation, the adults were analyzed by fluorescent microscopy
and Western blotting. (A) Western blotting analysis of the RNAi experiment. A representative
blot of three independent experiments is shown. The non-specific band by the GFP antibody is
marked by an asterisks. (B) Analysis of the YFP signal in intestinal cells. The scale bar represents
10 µm. Representative images of three independent experiments are shown. (C) Analysis of the
YFP signal in hypodermal cells. Fiji background subtraction with a rolling ball radius of five
pixels was applied. The scale bar represents 10 µm. Representative images of three independent
experiments are shown. (D) The violin plot shows the distribution of the fluorescence intensity
of the peroxisomes in hypodermal cells. The white dot represents the median. n=total number of












Figure 3.9: Continued: (E) Fluorescent microscopy analysis of the Pdaf-22YFP::dhfr
mut::PTS1 and
Pvha-7mCherry::PTS1 (bcSi112;bcEx1375) reporter treated with mock control or lonp-2(RNAi).
The scale bar represents 5 µm. Representative images of one experiment are shown.
peroxisome slightly increased and, additionally, a small fraction of peroxisomes showed
a very strong YFP signal upon the knock-down of lonp-2 (Figure 3.9C, D). Additionally,
the number of YFP-positive peroxisomes increased upon lonp-2(RNAi) or TMP treat-
ment. Qualitative analysis of the Pdaf-22YFP::dhfr
mut::PTS1 and Pvha-7mCherry::PTS1
(bcSi112;bcEx1375) reporter revealed that not all mCherry-positive peroxisomes also
contained YFP in mock treated animals, whereas the co-localization was almost complete
in lonp-2(RNAi) treated animals (Figure 3.9E). Since this experiment was only done once,
this observation is only a preliminary result but it suggests that the increase in YFP signal
observed in whole worm lysates is caused by an accumulation of YFP in the peroxisome.
3.2.3 The expression of an unfolded protein does not affect endogenous LONP-2
levels
To test if LONP-2 is up-regulated to degrade unfolded proteins, I analyzed endogenous
LONP-2 levels upon expression of DHFRmut in peroxisomes. The L4 larvae of the
Pdaf-22YFP::dhfr
mut::PTS1 (bcSi112) reporter strain were transferred onto TMP or DMSO
control plates. The reporter strain was analyzed after 6 h and 24 h of TMP treatment by
fluorescent microscopy and Western blotting. The transfer onto TMP should stabilize
DHFRmut. Thus, the load of unfolded proteins is reduced in these peroxisomes, which
might lead to a reduction of the LONP-2 levels. After 24 h growth on TMP plates, the
worms were transferred to DMSO plates. The effect of the washout of TMP was analyzed
at 3 h and 6 h post-transfer. Upon washout of TMP, the levels of unfolded proteins in
peroxisomes increase, which in turn might lead to an increase in LONP-2 levels. Fluores-
cent microscopy showed that the number of peroxisomes containing YFP increased upon
TMP treatment (Figure 3.10A). When DHFRmut was destabilized during the washout, the
number of YFP-positive peroxisomes again decreased. This was also reflected by an in-
creasing and subsequent decreasing band intensity of YFP in the Western blotting (Figure
3.10B). The effect of the stabilization and unfolding of DHFRmut on endogenous LONP-2
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levels was also analyzed by Western blotting. The LONP-2 levels upon TMP treatment or
washout did not change compared to the DMSO controls (Figure 3.10B). This experiment
indicates that the endogenous level of the peroxisomal Lon protease does not adjust to the
amount of unfolded protein present in the organelle under our experimental conditions.
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Figure 3.10: Expression of DHFRmut targeted to peroxisomes. (A) Time course of the stabilization
of DHFRmut by TMP. L4 larvae of the reporter Pdaf-22YFP::dhfr
mut::PTS1 (bcSi112) were treated
for 24 h with TMP and then transferred to DMSO plates for wash out. Additionally, control worms
remained continuously on DMSO plates. Analysis of the YFP signal in hypodermal cells by
fluorescent microscopy. Representative images of three independent experiments are shown. The
scale bar represents 10 µm. (B) Analysis of the time course experiment by Western blotting. The
LONP-2 band intensities were normalized to the respective Tubulin loading controls and quantified
relative to the DMSO 6 h control. The non-specific band by the GFP antibody is marked by an












3.3 The peroxisomal retrograde signaling pathway
3.3.1 Perturbation of peroxisomal biogenesis induces the peroxisomal retrograde
signaling
The aim of the study is to analyze the peroxisomal stress response. We hypothesized that
peroxisomal stress might induce a retrograde signaling similar to stress responses that
have been described for other organelles. It has been shown that stress in other organelles
leads to the transcriptional up-regulation of protease and chaperone genes (reviewed in
[Sasaki and Yoshida, 2015]). To test if the peroxisomal Lon protease is also part of such
a retrograde signaling for peroxisomes in C. elegans, I used different transcriptional re-
porter strains expressing a construct of 1 kb of the putative promoter of the peroxisomal
Lon protease lonp-2 fused to GFP (Plonp-2GFP) (Figure 3.11A). Two strains contained
multi-copy insertion alleles (bcIs126 and bcIs128) and one strain had a single-copy inser-
tion allele (bcSi75) of the Plonp-2GFP construct. To induce peroxisomal stress, I impaired
the peroxisomal biogenesis by individual knock-down of the 11 C. elegans homologs of
the human peroxins. L4 larvae of the Plonp-2GFP (bcIs128) multi-copy reporter strain
were subjected to the different peroxin knock-downs and the GFP expression was ana-
lyzed by fluorescent microscopy in adult animals of the next generation. The GFP inten-
sity was quantified and normalized to the negative control tag-208(RNAi). Knock-down
of tag-208 did not induce the reporter compared to the empty vector control mock (Figure
3.11A,B). Knock-down of prx-5, prx-11, prx-13, prx-14 and prx-19 led to a more than
2-fold induction of the Plonp-2GFP (bcIs128) reporter compared to tag-208(RNAi) (Figure
3.11). In contrast, prx-2(RNAi) did not induce the GFP expression of the reporter. The
knock-down of the remaining five peroxins led to a weak induction of the reporter. In gen-
eral, the reporter showed a high variation between the different experiments. The peroxins
that induce the reporter when knocked-down function in the peroxisomal biogenesis as re-
ceptors (PRX-5 and PRX-19), are part of the docking complex (PRX-13 and PRX-14) or
are required for peroxisomal division (PRX-11) (Figure 3.11C). Taken together, perturba-
tion of specific steps of peroxisomal biogenesis induces a retrograde signaling form the
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peroxisome to the nucleus (hereafter referred to as peroxisomal retrograde signaling or

















































































































































Figure 3.11: Inactivation of some peroxins leads to the transcriptional activation of the peroxiso-
mal Lon protease lonp-2. (A) Schematic of the Plonp-2GFP (bcIs128) reporter containing 1 kb of
the putative promoter of lonp-2 fused to GFP. L4 larvae carrying the reporter were subjected to the
knock-down of different peroxins. Adults of the next generation were analyzed by brightfield and
fluorescence microscopy. Representative images of RNAi conditions that induce the reporter more
than 2-fold are shown. The scale bar represents 0.5 mm. (B) The fluorescence intensity was quan-
tified relative to the negative control tag-208(RNAi) (Mean and SD are shown; n=3 (n=number of
biological replicates)). (C) C. elegans homologs of human peroxins. The numbers represent the
number of the respective peroxin (PRX). Proteins shown in dark grey induce a more than 2-fold












3.3.2 The peroxisomal Lon protease is transcriptionally up-regulated by a pertur-
bation of peroxisomal biogenesis
To confirm that the peroxisomal Lon protease is up-regulated upon the perturbation of
peroxisomal biogenesis, I tested the induction of the other two Plonp-2GFP reporters by
the knock-down of prx-5(RNAi) and prx-19(RNAi). prx-5 and prx-19 encode homologs of
the human receptors for peroxisomal matrix protein import PEX5 and peroxisomal mem-
brane protein insertion PEX19, respectively (Figure 3.11C). Since the receptors are the
most up-stream components of the import/insertion pathway of peroxisomal proteins, we
decided to focus our analysis on these two peroxins. Knock-down of prx-5 and prx-19
induced the Plonp-2GFP (bcIs126) multi-copy reporter about 2.4 and 2.7-fold, respec-
tively (Figure 3.12A). In contrast, the induction of the Plonp-2GFP (bcSi75) single-copy
reporter by knock-down of prx-5 and prx-19 was only 1.4-fold (Figure 3.12B). To con-
firm the observation by RNAi, I crossed the prx-5(tm4948) loss of function allele into
the Plonp-2GFP (bcIs126) multi-copy reporter. The prx-5(tm4948) homozygous mutation
induced the GFP expression of the reporter about 1.8-fold compared to wild-type (Figure
3.12C). To summarize, inactivation of the receptors required for peroxisomal biogenesis
induces the PRS. Since the Plonp-2GFP (bcIs126) multi-copy reporter showed a consistent
and strong induction, I used this reporter for further analysis of the PRS pathway.
Perturbation of the peroxisomal biogenesis induces the transcriptional up-regulation
of the peroxisomal Lon protease. Next, we asked if LONP-2 is also up-regulated on
the protein level. Therefore, I subjected wild-type L4 larvae to prx-5(RNAi) and prx-
19(RNAi) and analyzed adults of the next generation by Western blotting. Quantification
of the LONP-2 band intensities relative to the loading control Tubulin showed that the en-
dogenous LONP-2 levels were decreased by 30% upon prx-5(RNAi) compared to the con-
trol tag208(RNAi) (Figure 3.13A). In contrast, prx-19(RNAi) induced a 1.6-fold increase
in endogenous LONP-2 compared to the control. Additionally, I analyzed the LONP-2
levels in the prx-5(tm4948) mutant compared to the wild-type N2, which confirmed the
observation by prx-5(RNAi) (Figure 3.13B). These results indicate that impaired peroxi-
somal matrix protein import leads to a post-transcriptional and/or translational regulation
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Figure 3.12: Knock-down of the receptors required for peroxisomal biogenesis leads to the tran-
scriptional activation of the peroxisomal Lon protease. (A and B) Representative images and
quantification of the Plonp-2GFP reporters upon knock-down of prx-5 or prx-19. The RNAi clones
were diluted 1:2 with tag-208(RNAi) to reduce the slow growth phenotype. The scale bar rep-
resents 0.5 mm. (A) Analysis of the Plonp-2GFP (bcIs126) reporter. (Mean and SD are shown:
n=7 (n=number of biological replicates); ** p<0.01 and *** p<0.001 in a Welch’s ANOVA with
Games-Howell post hoc test to tag-208(RNAi)). (B) Analysis of the Plonp-2GFP (bcSi75) reporter.
(Mean and SD are shown: n=9 (n=number of biological replicates); ** p<0.01 in a Kruskal-Wallis
test with Dunn’s post hoc test to tag-208(RNAi)). (C) Representative images and quantification of
the Plonp-2GFP (bcIs126) reporter either wild-type (+/+) or carrying a prx-5(tm4948) mutation.
The scale bar represents 0.5 mm. (Mean and SD are shown: n=6 (n=number of biological repli-












of lonp-2 in addition to its transcriptional regulation. In contrast, perturbation of the per-
oxisomal membrane protein insertion leads to a transcriptional up-regulation of lonp-2 as



































































Figure 3.13: Perturbation of peroxisomal biogenesis affects endogenous LONP-2 protein levels.
(A) Wild-type L4 larvae were subjected to different RNAi. The RNAi clones were diluted 1:2
with tag-208(RNAi) to reduce the slow growth phenotype. Adults of the next generation were
lysed and analyzed by Western blotting. The LONP-2 band intensities were normalized to the
respective Tubulin loading controls and quantified relative to the negative control tag-208(RNAi).
(Mean and SD are shown. n=4 (n=number of independent experiments)). (B) Staged populations
of either wild-type (+/+) or prx-5(tm4948) mutant day 1 adults were analyzed by Western blotting.
The LONP-2 band intensities were normalized to the respective Tubulin loading controls and
quantified relative to the wild-type. (Mean and SD are shown. n=3 (n=number of biological
replicates)).
3.3.3 The peroxisomal catalase is transcriptionally up-regulated by a perturbation
of peroxisomal biogenesis
We hypothesized that the peroxisomal catalase CTL-2 might also be part of the PRS,
as it is required to degrade toxic hydrogen peroxide produced in peroxisomes. To test
this hypothesis, I generated a Pctl-2GFP (bcSi76) single-copy reporter (Figure 3.14A). L4
larvae of the reporter strain were subjected to the knock-down of the two peroxisomal
biogenesis receptors and the GFP fluorescence was analyzed in adult animals of the next
generation. The negative control tag-208(RNAi) did not induce the reporter compared to
the empty vector control mock (Figure 3.14A, B). Upon knock-down of prx-5 and prx-
19, the reporter was induced 1.7 and 1.8-fold compared to tag-208(RNAi), respectively
(Figure 3.14A, B).
To confirm the observations by RNAi, I generated a Pctl-2GFP (bcSi76) reporter car-
rying the prx-5(tm4948) homozygous mutation. The reporter was induced 4.7-fold com-
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pared to wild-type (Figure 3.14C). These results show that the peroxisomal catalase is




























































































































































Figure 3.14: Perturbation of peroxisomal biogenesis leads to the transcriptional up-regulation of
the peroxisomal catalase. (A) Schematic of the Pctl-2GFP (bcSi76) reporter containing 1.6 kb of the
putative promoter of ctl-2 fused to GFP. L4 larvae carrying the Pctl-2GFP (bcSi76) reporter were
subjected to different RNAi. The RNAi clones were diluted 1:2 with tag-208(RNAi) to reduce the
slow growth phenotype. Adults of the next generation were analyzed by brightfield and fluores-
cence microscopy. Representative images are shown and the scale bar represents 0.5 mm. (B) The
fluorescence intensity was quantified relative to the negative control tag-208(RNAi). (Mean and
SD are shown: n=10-12 (n=number of biological replicates); n.s.=not significant, *** p<0.001
in a Welch’s ANOVA with Games-Howell post hoc test to tag-208(RNAi)). (C) Representative
images and quantification of the Pctl-2GFP (bcSi76) reporter either wild-type (+/+) or carrying
a prx-5(tm4948)) mutation. The scale bar represents 0.5 mm. (Mean and SD are shown: n=6
(n=number of biological replicates); *** p< 0.001 in a Welch two-sample t-test).
3.3.4 The peroxisomal retrograde signaling is dependent on the nuclear hormone
receptor NHR-49
To identify transcription factors involved in the PRS pathway, I conducted a candidate
screen. As candidates, we chose transcription factors that were predicted to bind to the












porter strains. Furthermore, we included transcription factors that have previously been
shown to be required for the regulation of peroxisomal genes. The GFP expression of the
Plonp-2GFP (bcIs126) reporter strain was induced by prx-19(RNAi) and I tested for the
suppression of the GFP expression upon additional knock-down of the transcription fac-
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Figure 3.15: Candidate screen for suppressors of the PRS. L4 larvae carrying the Plonp-2GFP
(bcIs126) reporter were subjected to double RNAi. They were treated with prx-19(RNAi) and
RNAi clones against candidate transcription factors. Adults of the next generation were analyzed
by brightfield and fluorescence microscopy and screened for suppression of the GFP expression.
Representative images are shown and the scale bar represents 0.5 mm. (n=3 (n=number of inde-
pendent experiments)).
To confirm the result, the double RNAi experiment was repeated with the Plonp-2GFP
(bcIs126) and the Pctl-2GFP (bcSi76) reporter strains. Knock-down of nhr-49 suppressed
the GFP expression of the Plonp-2GFP (bcIs126) reporter strain induced by prx-5(RNAi)
and prx-19(RNAi) (Figure 3.16A). The GFP level decreased to 0.7-fold (prx-5(RNAi)
+ nhr-49(RNAi)) and 0.3-fold (prx-19(RNAi) + nhr-49(RNAi)) compared to the con-
trol tag-208(RNAi). Under nhr-49(RNAi) conditions, GFP expression of the Pctl-2GFP
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Figure 3.16: The PRS pathway is dependent on NHR-49. (A and B) Quantification of the sup-
pression of the PRS by NHR-49. L4 larvae carrying the Plonp-2GFP (bcIs126) (A) or Pctl-2GFP
(bcSi76) (B) reporter were subjected to double RNAi and adults of the next generation were an-
alyzed and fluorescence microscopy. The RNAi clones were diluted 1:2. Quantification of the
fluorescence intensity relative to tag-208(RNAi). (Mean and SD are shown: n=6-12 (n=number
of biological replicates); ** p<0.01 and *** p<0.001 in a Welch’s ANOVA with Games-Howell
post hoc test). (C and D) Dependence of the basal expression of lonp-2 and ctl-2 on NHR-49. The
RNAi clones were diluted 1:2. (Mean and SD are shown: n=6 (n=number of biological replicates);
*** p<0.001 by a two sample t-test (C). n.s.=not significant by a Mann-Whitney-Wilcoxon-U-Test
(D)). (E) Dependence of endogenous LONP-2 levels on NHR-49. Staged populations of either
wild-type (+/+) or nhr-49(gk405) mutant day 1 adults were analyzed by Western blotting. The
LONP-2 band intensities were normalized to the respective Tubulin loading controls and quanti-












(bcSi76) reporter strain was no longer up-regulated by prx-5(RNAi) and prx-19(RNAi)
(Figure 3.16B). Furthermore, a knock-down of nhr-49 in the control (tag-208(RNAi) +
nhr-49(RNAi)) led to a decrease in GFP expression of the Plonp-2GFP (bcIs126) reporter
strain indicating that basal lonp-2 expression is dependent on NHR-49 (Figure 3.16C),
whereas the basal expression of ctl-2 was not dependent on NHR-49 (Figure 3.16D). In
contrast to the transcriptional regulation of lonp-2 by nhr-49, the endogenous LONP-2
level was only slightly decreased in the nhr-49(gk405) mutant compared to the wild-type
(Figure 3.16E). Taken together, I identified the nuclear hormone receptor NHR-49 as a
transcription factor required for the PRS pathway.
3.3.5 The peroxisomal retrograde signaling is dependent on the NHR-49 co-factor
MDT-15
It has been shown that NHR-49 can regulate different pathways depending on its inter-
acting co-factor [Pathare et al., 2012]. I hypothesized that also the regulation of PRS by
NHR-49 requires a co-factor. Therefore, I knocked-down all six NHR-49 co-factors that
have previously been identified [Pathare et al., 2012]. Furthermore, I tested other factors
that have been shown to interact with NHR-49 [Xu et al., 2011, Liang et al., 2010, Cuppen
et al., 2003]. Only the knock-down of mdt-15, which is an ortholog of the mammalian
mediator subunit MED15, led to a suppression of the GFP expression of the Plonp-2GFP
(bcIs126) reporter induced by prx-19(RNAi) (Figure 3.17).
Repetition of the experiment showed that mdt-15(RNAi) suppressed the GFP expres-
sion of the Plonp-2GFP (bcIs126) and Pctl-2GFP (bcSi76) reporter strains induced by either
prx-5(RNAi) or prx-19(RNAi) (Figure 3.18A, B). Upon mdt-15(RNAi), the induction of
the Plonp-2GFP (bcIs126) reporter strain by prx-5(RNAi) and prx-19(RNAi) was reduced
to 0.6-fold and 0.8-fold compared to tag-208(RNAi), respectively (Figure 3.18A). Under
these double RNAi conditions, the GFP expression of the Pctl-2GFP (bcSi76) reporter
was similar to the tag-208(RNAi) levels (Figure 3.18B). The knock-down of mdt-15 in
the control (tag-208(RNAi) + mdt-15(RNAi)) showed that the basal expression of lonp-2
and ctl-2 is dependent on MDT-15 (Figure 3.18C, D). To summarize, the PRS pathway is
dependent on the NHR-49 co-factor MDT-15.
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Figure 3.17: Dependence of the PRS on NHR-49 co-factors. L4 larvae carrying the Plonp-2GFP
(bcIs126) reporter were subjected to double RNAi. They were treated with prx-19(RNAi) and
RNAi clones against NHR-49 co-factors. Adults of the next generation were analyzed by bright-
field and fluorescence microscopy and screened for suppression of the GFP expression. Repre-
sentative images are shown and the scale bar represents 0.5 mm. (n=6 (n=number of biological
replicates)).
3.3.6 The peroxisomal retrograde signaling is induced by a block of peroxisomal
beta-oxidation
The knock-down of prx-5 might affect the import of peroxisomal beta-oxidation enzymes.
By this, the peroxisomal beta-oxidation might be reduced, which could lead to an accumu-
lation of fatty acids that would not be degraded in the peroxisomes. Accumulated lipids
or fatty acids could act as signaling molecules in the PRS pathway. To test this hypoth-
esis, we decided to block peroxisomal beta-oxidation, which leads to an accumulation
of fatty acids. Peroxisomal beta-oxidation not only degrades fatty acids but also reduces
the chain length of ascarosides, which are nematode specific pheromones. Enzymes re-
quired for ascaroside biosynthesis can function in the beta-oxidation of ascarosides as
well as of triacylglyerols [Zhang et al., 2010, von Reuss et al., 2012, Artyukhin et al.,


















































































































































































































































































































































Figure 3.18: The PRS pathway is dependent on the NHR-49 co-factor MDT-15. (A and B) L4
larvae carrying the Plonp-2GFP (bcIs126) (A) or Pctl-2GFP (bcSi76) (B) reporter were subjected to
double RNAi. Adults of the next generation were analyzed by fluorescence microscopy and the
fluorescence intensity was quantificed relative to tag-208(RNAi). The RNAi clones were diluted
1:2. (Mean and SD are shown: n=6-14 (n=number of biological replicates); ** p<0.01 and ***
p<0.001 in a (Welch’s) ANOVA with Games-Howell or TukeyHSD post hoc test). (C and D)
Dependence of the basal expression of lonp-2 and ctl-2 on MDT-15. The RNAi clones were
diluted 1:2. (Mean and SD are shown: n=6-8 (n=number of biological replicates); *** p<0.001
by a two sample t-test).
et al., 2005, von Reuss et al., 2012] and analyzed the GFP expression of the Plonp-2GFP
(bcIs126) and Pctl-2GFP (bcSi76) reporters. First, the fatty acids or ascarosides are im-
ported into peroxisomes. Three ABC subfamily D proteins have been proposed to be
involved in the transport of fatty acids into peroxisomes [van Roermund et al., 2011, van
Roermund et al., 2014]. In C. elegans, homologs of these ABCD proteins are encoded by
five pmp genes. Only PMP-1, PMP-2 and PMP-4 have been shown to localize to perox-
isomes [Lee et al., 2014]. Since the RNAi clones for pmp-1 and pmp-2 were not present
in our RNAi libraries, I only tested the induction of GFP expression of the Plonp-2GFP
(bcIs126) and Pctl-2GFP (bcSi76) transcriptional reporters upon knock-down of pmp-4.
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Only the Pctl-2GFP (bcSi76) reporter was induced upon pmp-4(RNAi) (Figure 3.19). This
suggests that an accumulation of fatty acids in the cytosol only partially induces the PRS.
However, it is possible that the transporters act redundantly.
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Figure 3.19: The PRS is induced by a block of peroxisomal beta-oxidation. L4 larvae carrying the
Plonp-2GFP (bcIs126) or Pctl-2GFP (bcSi76) reporter were subjected to RNAi against peroxisomal
beta-oxidation enzymes. Adults of the next generation were analyzed by fluorescence microscopy.
The fluorescence intensity was quantified relative to the negative control tag-208(RNAi). (Mean
and SD are shown: n=6-36 (n=number of biological replicates); n.d.=not determined).
Knock-down of several enzymes that function in peroxisomal beta-oxidation (acox,
dhs-28, maoc-1 and daf-22) induced the PRS about 2-fold (Figure 3.19, 3.20A, B). More
specifically, I knocked-down the six genes encoding acyl-CoA oxidases in C. elegans
(acox-1.1 to acox-1.6), which catalyze the first step of the peroxisomal beta-oxidation.
Only the knock-down of the genes encoding the acyl-CoA oxidases ACOX-1.1 and
ACOX-1.3 led to an increase in GFP expression in both reporter strains. The bifunc-
tional enzyme is acting down-stream of the acyl-CoA oxidase. Knock-down of dhs-28
and maoc-1 induced the GFP expression of both reporters, whereas knock-down of ech-3,
ech-6 and ech-9 did not change the GFP expression. The last step of peroxisomal beta-












of the human ACAA1 kat-1 was not tested . However, knock-down of the homolog of the
human SCPx daf-22 induced both reporters. Additionally, the Plonp-2GFP (bcIs126) and
Pctl-2GFP (bcSi76) reporters carrying a daf-22(m130) mutation showed an increased GFP
expression compared to wild-type (Figure 3.20C,D). ACS-7 and ACOX-3 are required
to further modify ascaroside pheromones [Zhou et al., 2018]. Knock-down of acs-7 and
acox-3 did not result in an increase in GFP expression of both reporters (Figure 3.20A,B).
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Figure 3.20: The PRS is induced by a block of peroxisomal beta-oxidation. (A and B) L4 larvae
carrying the Plonp-2GFP (bcIs126) (A) or Pctl-2GFP (bcSi76) (B) reporter were subjected to RNAi
against peroxisomal beta-oxidation enzymes. Adults of the next generation were analyzed by
brightfield and fluorescence microscopy. The fluorescence intensity was quantified relative to
the negative control tag-208(RNAi). (Mean and SD are shown: n=6-14 (n=number of biological
replicates); n.s.=not significant, * p<0.05, ** p<0.01 and *** p<0.001 in a Welch’s ANOVA
with Games-Howell post hoc test to tag-208(RNAi)). (C and D) Quantification of the fluorescence
intensity of the Plonp-2GFP (bcIs126) (C) or Pctl-2GFP (bcSi76) (D) reporter either wild-type (+/+)
or carrying a daf-22(m130) mutation. (Mean and SD are shown: n=3-4 (n=number of biological
replicates); ** p< 0.01 in a two-sample t-test).
Next, we asked if the induction of the PRS by the knock-down of beta-oxidation genes
is dependent on NHR-49. To this end, I induced the GFP expression in the Plonp-2GFP
(bcIs126) and Pctl-2GFP (bcSi76) reporters by the knock-down of maoc-1 (Figure 3.21).
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Additional knock-down of nhr-49 suppressed the response. This shows that the PRS path-
















































































































































Figure 3.21: Dependence of induction of PRS by the block of peroxisomal beta-oxidation on
NHR-49. L4 larvae carrying the Plonp-2GFP (bcIs126) (A) or Pctl-2GFP (bcSi76) (B) reporter
were subjected to double RNAi. The RNAi clones were diluted 1:2. The fluoresence intensity of
adults of the next generation was quantified relative to tag-208(RNAi). (Mean and SD are shown:
n=6 (n=number of biological replicates); ** p<0.01 and *** p<0.001 in a (Welch’s) two-sample
t-test).
To show that perturbation of peroxisomal matrix protein import by prx-5(RNAi) indi-
rectly leads to an accumulation of fatty acids, wild-type L4 larvae were stained with the
fat-soluble dye Oil Red O. Animals with higher fat content incorporate more of the dye
and, therefore, show a stronger staining. Surprisingly, animals treated with tag-208(RNAi)
showed a slight increase in signal intensity compared to the empty vector control mock.
The fat content of animals treated with prx-5(RNAi) had a comparable signal intensity
compared to mock (Figure 3.22). Thus, perturbation of peroxisomal matrix protein im-
port does not lead to a detectable accumulation of fatty acids.
3.3.7 Block of mitochondrial beta-oxidation does not induce the peroxisomal ret-
rograde signaling
Very long-chain and long-chain fatty acids are first shortened by peroxisomal beta-
oxidation and then further degraded in mitochondria. Therefore, we asked if a block
of mitochondrial beta-oxidation also induces the PRS. To this end, I knocked-down two




















































Figure 3.22: Wild-type L4 larvae were treated with different RNAi and the animals of the next
generation were stained with Oil Red O. prx-5(RNAi) was diluted 1:2 with mock to reduce the
slow-growth phenotype. Representative images are shown. The scale bar represents 200 µm.
Quantification of the signal intensity of the staining. (n=39-50 (n=number of animals analyzed
from 3 independent experiments); n.s.=not significant and *** p<0.001 by a Kruskal Wallis test
with Dunn’s post hoc test).
expression of the Plonp-2GFP (bcIs126) and Pctl-2GFP (bcSi76) reporters. Knock-down
of ech-6 and acdh-13 did not affect the expression of the PRS reporters (Figure 3.23A,
B). In contrast, ech-6(RNAi) and acdh-13(RNAi) caused a strong up-regulation of the mi-
tochondrial unfolded protein response transcriptional reporter Phsp-6GFP (zcIs13) (Figure
3.23C). Conversely, knock-down of maoc-1, which caused an up-regulation of the PRS
reporters, did not affect the Phsp-6GFP (zcIs13) reporter (Figure 3.23). To summarize,
these results indicate that the PRS is specifically activated by a perturbation of peroxiso-
mal beta-oxidation. Interestingly, prx-5(RNAi) weakly induced the UPRmt transcriptional
reporter (Figure 3.23C). This hints at the existence of a cross talk between the mitochon-
drial and the peroxisomal stress responses, which will be further discussed below (see
chapter 3.4).
3.3.8 The PRS is not induced by a redox imbalance between peroxisomes and the
cytosol
We observed that a perturbation of peroxisomal beta-oxidation induces the PRS. There-
fore, one can speculate that fatty acids act as signaling molecules in the PRS. However,
it is also conceivable that reactive oxygen species (ROS) act as signaling molecules in
the PRS, since many metabolic pathways taking place in peroxisomes generate ROS
like hydrogen peroxide (see chapter 1.4). Hydrogen peroxide derived from peroxisomes
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Plonp-2GFP (bcIs126) Pctl-2GFP (bcSi76)
C
Phsp-6GFP (zcIs13)
Figure 3.23: The PRS is specifically induced by a perturbation of peroxisomal beta-oxidation. L4
larvae carrying the Plonp-2GFP (bcIs126) (A), Pctl-2GFP (bcSi76) (B) or Phsp-6GFP (zcIs13) (C)
reporter were subjected to different RNAi conditions. The prx-5(RNAi) clone was diluted 1:2 with
tag-208(RNAi) to reduce the slow growth phenotype. The fluorescence intensity of the reporters in
adults of the next generation was quantified relative to the negative control tag-208(RNAi). (Mean
and SD are shown: n=6-8 (n=number of biological replicates); n.s.=not significant, * p<0.05,
** p<0.01 and *** p<0.001 in a Welch’s ANOVA with Games-Howell post hoc test to tag-
208(RNAi)).
can modulate various biological processes and the peroxisomal catalase is an impor-
tant enzyme to maintain balanced hydrogen peroxide levels in the cell [Brown et al.,
1999, Koepke et al., 2008, Ivashchenko et al., 2011]. We hypothesized that the knock-
down of prx-5 might result in a decreased import of the peroxisomal catalase CTL-2 and
thus in a disruption of the redox balance between peroxisomes and the cytosol. Besides
the peroxisomal catalase CTL-2, C. elegans has also a cytosolic catalase CTL-1. A third
catalase CTL-3 also exists in a small subset of cells, but its sub-cellular localization has
not been analyzed [Petriv and Rachubinski, 2004]. The knock-down of ctl-1 and ctl-2
would lead to a disruption of the ROS metabolism in the cytosol and the peroxisome,
respectively. The resulting imbalance of the redox state between the two compartments
might induce the PRS.
To test this hypothesis, I analyzed the GFP expression of the Plonp-2GFP (bcIs126)
and Pctl-2GFP (bcSi76) reporters upon knock-down of ctl-1 and ctl-2. Neither RNAi
condition induced the transcriptional reporters compared to the control tag-208(RNAi)
(Figure 3.24A, B). Consistent with the result of ctl-2(RNAi), the ctl-2(ua90) mutation
also did not cause an up-regulation of the Plonp-2GFP (bcIs126) and Pctl-2GFP (bcSi76)















































































































































































































































































Plonp-2GFP (bcIs126) Pctl-2GFP (bcSi76)
B
Figure 3.24: The PRS is not induced by a redox imbalance between peroxisomes and the cy-
tosol. (A and B) L4 larvae carrying the Plonp-2GFP (bcIs126) (A) or Pctl-2GFP (bcSi76) (B)
reporters were subjected to different RNAi and adults of the next generation were analyzed by
brightfield and fluorescence microscopy. The expression of the reporters was quantified relative
to tag-208(RNAi). (n=6 (n=number of biological replicates); mean and SD are shown; n.s.=not
significant, ** p<0.01 by a Welch’s ANOVA with Games-Howell post hoc test and * p<0.05
by a Kruskal-Wallis test with Dunn’s multiple comparisons test to tag-208(RNAi)). (C and D)
Brightfield and fluorescence microscopy analysis of the fluorescence intensity of the Plonp-2GFP
(bcIs126) (C) or Pctl-2GFP (bcSi76) (D) reporters carrying the ctl-2(ua90) mutation and the re-
spective wild-type (+/+) strain. (n=6 (n=number of biological replicates); mean and SD are shown;
ns=not significant by a two sample t-test).
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in the upstream and 5’ region of the ctl-2 gene and results in lack of detectable CTL-2
activity [Petriv and Rachubinski, 2004]. Taken together, this experiment indicates that a
perturbation of the redox balance between peroxisomes and the cytosol does not induce
the PRS.
3.3.9 Genes involved in the defense response and lipid metabolic processes are up-
regulated in the PRS
We identified the peroxisomal Lon protease and peroxisomal catalase as effector genes
of the PRS. Next, we aimed to identify further effector genes by analyzing the C. ele-
gans transcriptome upon induction of the PRS. To this end, we knocked-down prx-5
in wild-type animals and adults of the next generation were analyzed by RNA-seq by
Eurofins Genomics Germany GmbH. tag-208(RNAi) served as a negative control. Out
of 15,796 identified genes, 1,372 genes were significantly up-regulated and 662 genes
were significantly down-regulated in prx-5(RNAi) samples compared to control samples
(FDR<0.05) (Figure 3.25A). I analyzed the dataset using gene set enrichment analysis
(GSEA). The advantage of this analysis is that no arbitrary cut-off is applied and the
direction of change is taken into account. GSEA of Kyoto Encyclopedia of Genes and
Genomes (KEGG) pathways using WebGestalt [Liao et al., 2019] revealed a strong en-
richment of the pathways ”peroxisome” (cel04146) and ”lysosome” (cel0414) (Figure
3.25B, Appendix Table A.1). Furthermore, several metabolic pathways like for example
”fatty acid elongation” (cel00062) or ”metabolism of xenobiotics by cytochrome P450”
(cel00980) were enriched. In contrast, genes that are assigned to for example the pathways
”ribosome” (cel03010), ”spliceosome” (cel03040) and ”proteasome” (cel03050) were un-
derrepresented under prx-5(RNAi) conditions.
To reduce the number of significantly changed genes, we chose a cut-off of a log2(fold
change) value ≥1 (increased) or ≤-1 (decreased) and asked which KEGG pathways or
Gene Ontology (GO) terms were enriched among these genes with a stronger differen-
tial expression. This cut-off resulted in a list of 1,157 genes that were significantly up-
regulated and 267 genes that were significantly down-regulated. KEGG pathway enrich-
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Figure 3.25: RNA-seq analysis of genes differentially expressed upon knock-down of prx-5. (A)
Wild-type L4 larvae were subjected to prx-5(RNAi) and tag-208(RNAi) and adults of the next gen-
eration were analyzed by RNA-seq. The prx-5(RNAi) clone was diluted 1:2 with tag-208(RNAi) to
reduce the slow growth phenotype. The heat map shows the z-score of genes significantly changed
(FDR<0.05) of tag-208(RNAi) control samples and prx-5(RNAi) samples. (n=3 (n=number of bio-
logical replicates)). (B) Gene set enrichment analysis of KEGG pathways in prx-5(RNAi) samples
compared to tag-208(RNAi) control samples. (C) KEGG pathway enrichment analysis of genes
significantly changed upon prx-5(RNAi). Genes with a log2(fold change) value ≥1 (increased) or
≤-1 (decreased) and an FDR<0.05 were considered as significantly changed. (D) GO enrichment
analysis of genes significantly changed upon prx-5(RNAi) summarized using REVIGO. Genes
with a log2(fold change) value ≥1 (increased) or ≤-1 (decreased) and an FDR<0.05 were con-
sidered as significantly changed. GO terms are represented by circles and are plotted according
to semantic similarities to other GO terms (adjoining circles are most closely related). The color
indicates the log10(p-value).
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the GSEA, the pathways ”peroxisome” (cel04146; p=1.96e-15) and ”lysosome” (cel0414;
p=2.19e-13) were enriched (Figure 3.25C, Appendix Table A.2). In contrast, the en-
riched metabolic pathways only partially overlapped between the two analyses. While
the pathways ”fatty acid elongation” (cel00062) and ”metabolism of xenobiotics by cy-
tochrome P450” (cel00980) were enriched in both datasets, the pathways for amino acid
metabolism (”lysine degradation” (cel00310; p=1.75e-02) and ”tryptophan metabolism”
(cel00380; p=5.27e-02)) were only enriched in the dataset with high differential expres-
sion. GO enrichment analysis of the domain ”biological process” of this dataset using
GOrilla [Eden et al., 2009] and REVIGO [Supek et al., 2011] revealed two large clusters
of enriched GO terms (Figure 3.25D, Appendix Table A.3). Representative terms of these
clusters are ”defense response” (GO:0006952; p=1.06e-35) and ”lipid metabolic process”
(GO:0006629; p=3.72e-10). Notably, about 95% of the genes assigned to these two bi-
ological processes were up-regulated upon knock-down of prx-5. Taken together, the
GSEA, KEGG pathway enrichment analysis and GO enrichment analysis showed match-
ing results. For instance, lipid metabolic processes were enriched in all three analyses.
Furthermore, the degradation of fatty acids takes place in peroxisomes, which were also
enriched in the GSEA and KEGG pathway enrichment analysis.
To test if specific peroxisomal pathways were enriched, I mapped the significantly
changed genes to KEGG pathways using KEGG Mapper [Kanehisa and Sato, 2020].
Analysis of the mapping result of the KEGG pathway ”peroxisome” (cel04146) showed
that all genes mapped to this pathway were significantly up-regulated. Specifically, genes
coding for components of the alpha- and beta-oxidation pathways as well as the ether-
phospholipid biosynthesis and were significantly up-regulated (Figure 3.26). In contrast,
only specific genes required for amino acid metabolism and the antioxidant system were
up-regulated. Moreover, almost all genes coding for peroxins were up-regulated. Specifi-
cally, only prx-11 and prx-19 were not significantly changed and prx-14 and prx-10 were
not determined in the RNA-seq analysis. Surprisingly, prx-5 was also up-regulated al-
though it was knocked-down by RNAi. However, this up-regulation could be part of the
response. For instance, it has been shown for mitochondria, that the induction of UPRmt












Figure 3.26: KEGG Mapper result of genes significantly changed upon prx-5(RNAi). The KEGG
pathway map ”peroxisome” (cel04146) is shown. Components of the pathway that have a ho-
molog in C. elegans are colored. Components of which at least one gene is significantly changed
(FDR<0.05 and log2(fold change) ≥1) are shown in blue and components that are not significantly
changed are shown in green.
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tional up-regulation of spg-7 [Nargund et al., 2012].
In general, the assignment of genes to KEGG pathways or GO terms is mostly done
automatically and can therefore be incomplete. For example, the KEGG pathway map
”peroxisome” (cel04146) shows that there is no homolog of the human PEX1 and PEX6
in C. elegans. However, homologs of genes encoding these two peroxins have been de-
scribed in the literature [Ghenea et al., 2001, Petriv et al., 2002]. Therefore, we manu-
ally generated a list of 62 peroxisomal proteins using WormBase (release WS272) [Lee
et al., 2017], PeroxisomeDB [Schluter et al., 2010] and literature research (Appendix
Table A.4). Genes coding for 57 of the 62 peroxisomal proteins were identified in the
RNA-seq analysis. 60% (34/57) of the identified genes were significantly up-regulated,
whereas none (0/57) of them was down-regulated. Interestingly, among the not signif-
icantly changed genes (23/57) were genes coding for proteins required for peroxisomal
biogenesis by fission (fis-1, fis-2, drp-1 and prx-11).
3.3.10 Proteins involved in the immune response and lipid metabolic processes are
up-regulated in the PRS
In light of the different regulation of the peroxisomal Lon protease at the transcriptional
and protein level, we aimed to analyze the C. elegans proteome upon induction of the PRS.
To this end, wild-type animals were subjected to prx-5(RNAi), prx-19(RNAi) and tag-
208(RNAi) as negative control. The protein lysates of the next generation were analyzed
by LC-MS by our collaborators Ignasi Forne and Axel Imhoff (BMC Munich). However,
the RNAi efficiency differed between the samples. The protein level of PRX-19 was not
significantly reduced by prx-19(RNAi). In contrast, the level of PRX-5 was significant re-
duced by 60% in the prx-5(RNAi) sample as compared to the control tag-208(RNAi) (Ap-
pendix Table B.1). Therefore, only the proteome of the prx-5(RNAi) samples was further
analyzed. Under these RNAi conditions, 6,353 proteins were identified, of which 120 pro-
teins were significantly up-regulated and 57 proteins were significantly down-regulated,
based on a p-value of < 0.05 and an expression change ratio of prx-5(RNAi) treated sam-
ples relative to the tag-208(RNAi) treated control samples with a log2(fold change) value












import receptor prx-5 is sufficient to induce changes in the C. elegans proteome.
First, I analyzed the protein-protein interaction network of the proteins significantly
changed upon prx-5(RNAi) using the database STRING [Szklarczyk et al., 2019]. The
analysis showed four different clusters (Figure 3.27B). The first cluster included peroxi-
somal proteins. Except for PRX-5, all proteins in this cluster were up-regulated and all of
them have been shown to be involved in peroxisomal fatty acid metabolism [Fredens et al.,
2011]. The second cluster comprised proteins that were up-regulated upon prx-5(RNAi)
and that have been shown to be involved in the C. elegans innate immune response [Hahm
et al., 2011, Liu et al., 2016, Yunger et al., 2017, Lee et al., 2013, Wong et al., 2007]. The
third cluster consisted of T28H10.3 and T22C1.3, two uncharacterized proteins that were
up-regulated upon prx-5(RNAi) and the other cluster with only two nodes consisted of
IFY-1 and F32D1.7, which were both down-regulated upon knock-down of prx-5.
The GO enrichment analysis of the significantly changed proteins revealed a simi-
lar result. The dataset was analyzed for GO enrichment using the GOrilla [Eden et al.,
2009] and REVIGO [Supek et al., 2011] (Appendix Table B.2). Two highly signifi-
cant representative GO terms of the domain ”biological process” were “lipid metabolic
process” (GO:006629, p=1.29e-05) and “immune response” (GO:006955; p=2.11e-05)
(Figure 3.27C). Examples for representative GO terms of the domain ”molecular func-
tion” were “acyl-CoA oxidase activity” (GO:0003997, p=3.45e-04) and “aspartic-type
endopeptidase activity” (GO:0004190, p=2.96e-05). Taken together, the enriched GO
terms of the two GO domains match each other as acyl-CoA oxidase activity is required
for lipid metabolic processes and the immune response involves the activity of endopepti-
dases. The GO enrichment and STRING analysis both provide evidence that peroxisomal
lipid metabolism and the immune response are the main biological processes, which are
affected upon knock-down of prx-5.
A more detailed analysis of the representative GO terms revealed that 90% of the pro-
teins assigned to the enriched GO terms were up-regulated upon knock-down of prx-5. In
the GO domain biological process, most of the proteins belonged to the GO term “lipid
metabolic process” (19 proteins) followed by the GO terms “immune system process” and
“immune response”, which were comprised of the same eleven proteins (Figure 3.27C).
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Figure 3.27: Analysis of changes of the proteome upon knock-down of prx-5. (A) The volcano plot
represents the log2(fold change) and -log10(p-value) of proteins identified in the LC-MS analysis
of prx-5(RNAi) samples compared to tag-208(RNAi) samples. The prx-5(RNAi) clone was diluted
1:2 with tag-208(RNAi) to reduce the slow growth phenotype. Proteins with a log2(fold change)
value ≥1 (increased) or ≤-1 (decreased) and p<0.05 by a limma moderated t-test were considered
as significantly changed. (B) Interaction analysis of proteins significantly changed upon prx-
5(RNAi) using STRING. The color of the nodes indicates the log2(fold change). Black lines show
co-expression, blue lines represent protein homology and purple lines represent experimentally
determined interactions. (C) GO enrichment analysis of proteins significantly changed upon prx-












In the GO domain molecular function, the majority of proteins was assigned to the GO
term “transferase activity, transferring glycosyl groups”. 7 of the 11 proteins assigned to
this GO were UDP-glucuronosyl transferases (UGT). Interestingly, several of the genes
encoding these proteins have been shown to be up-regulated in response to mitochondrial
stress (i.e. upon knock-down of the mitochondrial protease spg-7) [Nargund et al., 2012].
Therefore, UDP-glucuronosyl transferases may be part of a general stress response path-










Name Enzyme function Metabolic function




PMP-4 ABC class D transporter Fatty acid transport




















ZK550.6 Phytanoyl-CoA 2-hydoxylase Alpha-oxidation
F53C11.3 2,3-dienoyl-CoA reductase
GSTK-1 Gluthatione S transferase kappa Lipid metabolism
Beta-oxidation
Figure 3.28: Peroxisomal proteins that were significantly changed upon prx-5(RNAi). Proteins
with a log2(fold change) value ≥1 (increased) or ≤-1 (decreased) and p<0.05 by a limma mod-
erated t-test compared to tag-208(RNAi) were considered as significantly changed. The enzyme
function and metabolic pathway is based on experimental data in C. elegans or on homology to
the mammalian enzyme. (not determined: the enzyme was not detected by LC-MS).
The GO enrichment analysis of the domain cellular component revealed two enriched
GO terms: “microbody” (GO:0042579, p=5.35e-04) and “peroxisome” (GO:0005777,
p=1.90e-05). In the proteomic analysis, 53 of the 62 peroxisomal proteins (Appendix Ta-
ble A.4) were identified. PRX-5 was the only significantly down-regulated peroxisomal
protein and ∼25% (13/53) of the identified peroxisomal proteins were significantly up-
regulated upon prx-5(RNAi) (Figure 3.28). Only one of these up-regulated proteins was
a peroxisomal membrane protein (PMP-4) and the remaining were peroxisomal matrix
proteins. Among them was also the peroxisomal catalase (3.1-fold, p=0.012), which is
consistent with the transcriptional up-regulation of the Pctl-2GFP (bcSi76) reporter (see
chapter 3.3.1). In contrast, the protein levels of the peroxisomal Lon protease were
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not significantly changed (1.1-fold, p=0.874). In the Western blotting analysis of prx-
5(RNAi) samples, the endogenous LONP-2 levels were even decreased (see chapter 3.3.1).
Both observations support the hypothesis that lonp-2 is additionally regulated at the post-
transcriptional and/or translational level. Interestingly, all significantly up-regulated per-
oxisomal proteins are involved in lipid metabolism (Figure 3.28). Therefore, we hypoth-













































































































































































Figure 3.29: The thiolase daf-22 is up-regulated upon perturbation of peroxisomal biogenesis. (A)
L4 larvae carrying the Pdaf-22GFP (bcSi110) reporter were subjected to different RNAi and the ex-
pression of the reporter was analyzed by brightfield and fluorescent microscopy. The prx-5(RNAi)
and prx-19(RNAi) clones were diluted 1:2 with tag-208(RNAi) to reduce the slow growth pheno-
type. Representative images are shown. The scale bar represents 1 mm. (B) The fluorescence
intensity of the Pdaf-22GFP (bcSi110) reporter was quantified relative to the negative control tag-
208(RNAi). (Mean and SD are shown: n=6-13 (n=number of biological replicates); ** p<0.01
and *** p<0.001 by a Welch’s ANOVA with Games-Howell post hoc test to tag-208(RNAi)). (C)
Dependence of the induction on NHR-49. The RNAi clones were diluted 1:2. Quantification of
the reporter relative to the control tag-208(RNAi). (Mean and SD are shown: n=6 (n=number of
biological replicates); *** p<0.001 by a One-way ANOVA with Tukey HSD post hoc test.)
The protein level of the thiolase DAF-22 was up-regulated, albeit not significantly












22 is up-regulated at a transcriptional level, I generated a Pdaf-22GFP (bcSi110) reporter.
Upon perturbation of peroxisomal biogenesis by knock-down of prx-5 and prx-19, the
reporter was induced about 3-fold compared to the control tag-208(RNAi) (Figure 3.29A,
B). Moreover, a block of peroxisomal beta-oxidation by maoc-1(RNAi) also induced the
reporter (Figure 3.29A, B). Furthermore, the induction was dependent on NHR-49 and its
co-factor MDT-15 (Figure 3.29C). Taken together, daf-22 is also a target gene of the PRS.
Moreover, this experiment suggests that the PRS induced by prx-19(RNAi) also leads to
an up-regulation of peroxisomal beta-oxidation.
To summarize the results of this chapter, I have shown that perturbation of peroxisomal
biogenesis by knock-down of peroxins induces the PRS, which leads to the transcriptional
up-regulation of the peroxisomal Lon protease and peroxisomal catalase. Furthermore, I
have shown that the signaling pathway is dependent on the nuclear hormone receptor
NHR-49 and its co-factor MDT-15. Perturbation of peroxisomal biogenesis might lead
to impaired peroxisomal lipid metabolism. Indeed, I observed that knock-down of per-
oxisomal beta-oxidation enzymes also induced the PRS. Finally, transcriptomic and pro-
teomic analysis revealed that the activation of the PRS induces the up-regulation of lipid
metabolism enzymes and the innate immune response.
3.4 The mitochondrial chaperone hsp-6 is induced by a perturbation
of peroxisomal biogenesis
The knock-down of peroxisomal beta-oxidation genes specifically induced the PRS and
not the mitochondrial unfolded protein response (see chapter 3.3.6). In contrast, perturba-
tion of peroxisomal matrix protein import by prx-5(RNAi) induced both organellar stress
responses. Therefore, we asked if a perturbation of peroxisomal biogenesis is generally
inducing UPRmt. To this end, I subsequently knocked-down all peroxins and tested for
the induction of the UPRmt transcriptional reporter Phsp-6GFP (zcIs13). Knock-down of
prx-10 induced the reporter by about 20-fold compared to the control tag-208(RNAi) (Fig-
ure 3.30A, B). Sequencing of the RNAi clone revealed that it also targets wars-2, which
encodes the homolog of a mitochondrial tryptophanyl tRNA synthetase. Knock-down of
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prx-12 and prx-19 induced the GFP expression of the reporter about 3-fold compared to
the control tag-208(RNAi). In these experiments, the induction of the Phsp-6GFP (zcIs13)
reporter by prx-5(RNAi) was very weak. Taken together, the block of peroxisomal mem-
brane protein insertion and perturbation of PRX-5 recycling induces the UPRmt transcrip-

































































































































Figure 3.30: The UPRmt transcriptional reporter Phsp-6GFP (zcIs13) is induced upon perturbation
of peroxisomal biogenesis. (A) L4 larvae carrying the Phsp-6GFP (zcIs13) reporter were subjected
to different peroxin RNAi and the expression of the reporter was analyzed by brightfield and
fluorescent microscopy. Representative images of RNAi conditions that induce the reporter more
than 2-fold are shown. The scale bar represents 0.5 mm. (B) The fluorescence intensity of the
Phsp-6GFP (zcIs13) reporter was quantified relative to the negative control tag-208(RNAi) (n=4
(n=number of biological replicates)). (C) C. elegans homologs of human peroxins. The numbers
represent the number of the respective peroxin (PRX). Proteins shown in dark grey induce a more
than 2-fold transcriptional up-regulation of the Phsp-6GFP (zcIs13) reporter.
Since the results for the induction of UPRmt by the perturbation of peroxisomal bio-
genesis were not consistent, the experiment was repeated. The positive control spg-
7(RNAi) induced the reporter Phsp-6GFP (zcIs13) about 15-fold compared to the nega-
tive control tag-208(RNAi) (Figure 3.31A). spg-7 encodes the C. elegans homolog of the
mitochondrial peptidase AFG3L2. The induction of the reporter by knock-down of the












duced the reporter by 3.7-fold, albeit not significantly. To test if the induction is specific to
hsp-6, the experiment was repeated using the UPRmt transcriptional reporter Phsp-60GFP
(zcIs9). In this case, the positive control spg-7(RNAi) up-regulated the reporter 1.8-fold
and prx-12(RNAi) led to a 1.4-fold induction. However, in both conditions the induction
was not significant (Figure 3.31B). Since in this experiment the knock-down by RNAi was
not efficient enough, it is not possible to conclude if the induction of UPRmt is specific to
hsp-6.
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B C
Figure 3.31: HSP-6 is up-regulated upon perturbation of peroxisomal biogenesis. (A and B) L4
larvae carrying the UPRmt reporter were subjected to different RNAi and the expression of the
reporter was analyzed by fluorescent microscopy. The fluorescence intensity of the Phsp-6GFP
(zcIs13) reporter (A) and Phsp-60GFP (zcIs9) reporter (B) was quantified relative to the negative
control tag-208(RNAi). spg-7(RNAi) was diluted 1:5 with tag-208(RNAi) to reduce slow growth.
(Mean and SD are shown: n=5-11 (n=number of biological replicates); n.s.=not significant, *
p<0.05 and ** p<0.01 by a Welch’s ANOVA with Games-Howell post hoc test to tag-208(RNAi)).
(C) The same Western blot membrane as in chapter 2.6 was decorated with anti-HSP-6 and anti-
HSP-60 antibodies. The band intensities were normalized to the respective Tubulin loading con-
trols and quantified relative to the wild-type. (Mean and SD are shown: n=3 (n=number of biolog-
ical replicates)).
To avoid the issue of RNAi efficiency, I tested if the loss of function mutation prx-
5(tm4948) leads to an increase in the mitochondrial chaperones HSP-6 and HSP-60. West-
ern blotting analysis of prx-5(tm4948) animals revealed that the HSP-6 levels increased
1.4-fold compared to wild-type animals (Figure 3.31C). In contrast, the HSP-60 levels
decreased by 40%. Taken together, this experiment suggest that the perturbation of per-
oxisomal biogenesis causes an up-regulation of the mitochondrial chaperonne hsp-6 but
not hsp-60. It therefore remains to determined whether the perturbation of peroxisomal






4.1 Analysis of peroxisomes in C. elegans by fluorescent microscopy
To analyze the tissue-specific localization of peroxisomes in C. elegans, peroxisomes
were visualized by fluorescent microscopy. A fusion protein of the peroxisomal thiolase
DAF-22 with mKate2 was expressed under the control of the endogenous daf-22 pro-
moter (Pdaf-22mKate2::daf-22). Like previously reported, mKate2::DAF-22 labeled per-
oxisomes were observed in the intestine and the hypodermis [Yokota et al., 2002, Petriv
et al., 2002, Butcher et al., 2009]. Since these two tissues are the primary sites of fat stor-
age in C. elegans [Wang et al., 2011] and peroxisomes are required for the beta-oxidation
of stored fat [Srinivasan et al., 2008b], it seems logical that peroxisomes are present in
these tissues. Butcher et al. additionally described the expression of a GFP::DAF-22 re-
porter in body wall muscle cells [Butcher et al., 2009]. In my experiment, it was difficult
to determine if mKate2::DAF-22 labeled peroxisomes were present in body wall muscle
cells because of the strong expression of the reporter in the surrounding tissues. However,
I observed that head muscle cells only contain very few peroxisomes that only import low
amounts of the mKate2::DAF-22 fusion protein. Similar to the body wall muscle cells, it
was not possible to exactly determine if neurons contain peroxisomes. To overcome this
issue, reporters under the control of tissue-specific promoters could be used. Moreover,
reporters that label specific cells could be co-expressed to facilitate the identification of
the right cell. Additionally, using confocal instead of wide-field fluorescent microscopy
would improve the resolution and imaging contrast, thus reducing the problem of out-of-
focus light.
4.2 Characterization of the peroxisomal Lon protease in C. elegans
The peroxisomal Lon protease has not been characterized in C. elegans so far. I showed
that LONP-2 localizes to peroxisomes and that it is required for the degradation of an
unfolded protein that is targeted to peroxisomes (DHFRmut::PTS1). The unfolded protein
DHFRmut::PTS1 can be stabilized by the addition of the small molecule ligand TMP.
The experiment showed that in the absence of TMP, DHFRmut::PTS1 is very efficiently
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degraded by LONP-2, whereas upon addition of TMP, only a small faction is degraded.
This fraction might be not fully stabilized DHFRmut::PTS1 or LONP-2 is also required
for the degradation of proteins that are mislocalized peroxisomes. To test if LONP-2 is
required for the degradation of mislocalized proteins, a stable and correctly folded wild-
type form of DHFR could be targeted to peroxisomes. If LONP-2 is also required for the
degradation of the wild-type DHFR, it would accumulate under lonp-2(RNAi) conditions.
The experiment also suggested that the unfolded protein carrying a peroxisomal tar-
geting sequence is protected from the degradation in the cytosol and is imported into
peroxisomes in C. elegans. These results are similar to a study of the peroxisomal Lon
protease in the yeast Hansenula polymorpha [Aksam et al., 2007]. The authors suggest
that DHFRmut::PTS1 is protected from the degradation by the ubiquitin/proteasome sys-
tem in the cytosol but is then degraded in peroxisomes by the peroxisomal Lon protease.
However, Aksam et al. and I used Western analysis of whole cell/worm extracts as a
read out. Therefore, we cannot exclude that the accumulation of DHFRmut upon knock-
out/down of lonp-2 might also occur in the cytosol. However, I observed in a preliminary
fluorescence microscopy experiment an increase in YFP-tagged DHFRmut in peroxisomes
upon knock-down of lonp-2. Additionally, a cell fractionation assay could be done to ex-
clude this possibility.
Aksam et al. suggest that the degradation of peroxisomes by autophagy is another im-
portant mechanism to prevent the accumulation of non-functional peroxisomal proteins
or peroxisomes in yeast cells [Aksam et al., 2007]. However, they did not test if the ex-
pression of DHFRmut::PTS1 leads to the induction of autophagy or pexophagy. One way
to study pexophagy is the RedGreen-assay, which is a fluorescence-based technique used
to visualize the targeting of substrates to the autolysosome. The reporter construct con-
tains of a tandem GFP-mCherry that is targeted to peroxisomes. When the organelle is
targeted for degradation in the autolysosome, the GFP signal is quenched due to the low
pH environment and only the mCherry signal will be observed [Deosaran et al., 2013].
A similar reporter targeted to lysosomes has been used in C. elegans to study autophagy
[Chang et al., 2017]. The reporter Pdaf-22YFP::dhfr
mut::PTS1 and Pvha-7mCherry::PTS1













similar properties. I observed that without the stabilizing ligand some mCherry-labeled
peroxisomes colocalize with a weak YFP signal and others are YFP negative. Either the
YFP::DHFRmut in these peroxisomes was completely degraded by LONP-2 or these per-
oxisomes undergo pexophagy and therefore the YFP signal is quenched in the autolyso-
some. Using a lysosome marker could reveal if these peroxisomes are indeed localized
to lysosomes for degradation. In future, also a mCherry::GFP::PTS1 tandem reporter
could be used as a tool to analyze pexophagy. In this case, DHFRmut::PTS1 should not
be fused to YFP, because the GFP and YFP signals cannot be distinguished by wide-field
fluorescent microscopy.
We hypothesized that the increased level of an unfolded protein targeted to perox-
isomes could lead to an up-regulation of the peroxisomal Lon protease. However, the
expression of DHFRmut::PTS1 did not lead to a change in LONP-2 levels in a time course
experiment. Assuming that the time point when the LONP-2 levels changed was not
missed due to the experimental design, the data suggests that the levels of LONP-2 in per-
oxisomes are sufficient to cope with the overexpression of an unfolded protein targeted to
peroxisomes.
4.3 The peroxisomal retrograde signaling pathway
4.3.1 Proposed model for the PRS
In this thesis, I have identified for the first time the existence of retrograde signaling
pathway from peroxisomes to the nucleus (PRS) that is induced by the perturbation of
peroxisomal biogenesis by knock-down of peroxins (Figure 4.1). This signaling path-
way is dependent on the nuclear hormone receptor NHR-49 and its co-factor MDT-15.
We speculated that perturbation of peroxisomal biogenesis might lead to impaired perox-
isomal lipid metabolism. Consistent with this hypothesis, I showed that knock-down of
peroxisomal beta-oxidation enzymes also induced the PRS. We propose that the resulting
change in lipid composition might activate NHR-49 and its co-factor MDT-15 thereby
leading to the transcriptional up-regulation of the peroxisomal Lon protease. Moreover,
lipid metabolism enzymes and the innate immune response are up-regulated upon induc-
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tion of the PRS. We propose that this up-regulation represents a compensatory mecha-
nism, which is induced to restore the peroxisomal function in response to a perturbation
of peroxisomal biogenesis. The results that led to this proposed model are discussed in



































Figure 4.1: The peroxisomal retrograde signaling pathway. (A) Under physiological conditions,
some genes encoding peroxisomal proteins are under the control of the nuclear hormone receptor
NHR-49 and its co-factors. These proteins are imported into the peroxisomal matrix by the import
receptor PRX-5. (B) Peroxisomal stress due to perturbation of peroxisomal biogenesis leads to an
impaired peroxisomal beta-oxidation. We hypothesize that the resulting change in lipid composi-
tion activates NHR-49. It interacts with its co-factor MDT-15 and activates the expression of genes
coding for lipid metabolism enzymes and immune response proteins. We suggest that an increase
in the levels of these enzymes increases their probability to be recognized by the remaining PRX-5
receptors for import into peroxisomes.
4.3.2 The PRS is induced by a perturbation of peroxisomal biogenesis
To induce peroxisomal stress, all C. elegans homologs of human peroxins were subse-
quently knocked-down. Notably, the knock-down of the peroxins induced the transcrip-
tional up-regulation of the peroxisomal Lon protease to different extent. Specifically,
perturbation of the first steps of the peroxisomal matrix protein import pathway induces
the transcriptional response. For example, reduced levels of the import receptor PRX-5
and the components of its docking complex PRX-13 and PRX-14 strongly induced the
response. In contrast, perturbation of the following step, the receptor recycling, only led
to a weak induction. Similarly, reduced levels of the membrane protein receptor PRX-19
induces the response stronger than the knock-down of its docking partner PRX-3. There-













4.3.3 Perturbation of peroxisomal biogenesis induces an up-regulation of the per-
oxisomal Lon protease and the peroxisomal catalase
Peroxisomal import stress in C. elegans caused by the knock-down of the receptors prx-5
or prx-19 induced the up-regulation of the transcriptional reporters of the peroxisomal
Lon protease lonp-2. Interestingly, the LONP-2 protein levels only increased upon prx-
19(RNAi), whereas upon knock-down or knock-out of prx-5 the levels even decreased.
It is conceivable that upon reduction of peroxisomal membrane protein insertion by prx-
19(RNAi), LONP-2 can still be imported into the peroxisomal matrix. In contrast, upon
loss of the matrix protein import receptor PRX-5, the peroxisomal Lon protease might
accumulate in the cytosol, which could be harmful for the cell. Therefore, a post-
transcriptional and/or post-translational regulation of LONP-2 might exist. This obser-
vation is similar to the regulation of the mitochondrial Lon protease LONP1 during the
mitochondrial unfolded protein response. LONP1 is up-regulated at the transcriptional
level but this does not result in an increased protein level, which is consistent with several
post-transcriptional responses occurring during UPRmt (e.g. protein degradation, attenu-
ation of protein synthesis or mitophagy) [Fiorese et al., 2016].
In contrast to LONP-2, knock-down of prx-5 led to the transcriptional up-regulation
of the peroxisomal catalase ctl-2, which resulted in increased CTL-2 protein levels. This
indicates that the cell does not need to counteract a cytosolic accumulation of the per-
oxisomal catalase. Conversely, it even has been shown in PEX5-/- mouse embryonic fi-
broblasts that a cytosolic localization of catalase can protect the cytosol against oxidative
stress [Walton et al., 2017].
4.3.4 The PRS is regulated by the transcription factor NHR-49 and its co-factor
MDT-15
We define the up-regulation of effector genes upon peroxisomal biogenesis stress as per-
oxisomal retrograde signaling. The retrograde signal from the peroxisome to the nucleus
is dependent on the nuclear hormone receptor NHR-49 and its co-factor MDT-15. It is
possible, that other transcription factors are also involved in the response but that the
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knock-down in the double RNAi experiment was not efficient enough to show a sup-
pression. Strains that carry mutations in the respective genes could be used to verify the
observations by RNAi. Moreover, only selected candidates were tested. Thus, a genome-
wide suppressor screen could reveal more candidates required for the induction of the
PRS.
The experiment showed that in the absence of peroxisomal stress, the basal expression
of lonp-2 is dependent on NHR-49, whereas the basal expression of ctl-2 is not. This
observation is also reflected at the protein level as shown by a published nhr-49(RNAi)
proteome [Fredens et al., 2011]. Comparison of the prx-5(RNAi) proteomic data with the
nhr-49(RNAi) proteome revealed that only about a quarter of the proteins changed upon
prx-5(RNAi) are regulated by NHR-49 under physiological conditions (i.e. in the absence
of peroxisomal import stress). This suggests that NHR-49 can activate the expression
of genes upon peroxisomal import stress, although these genes are not under its control
under physiological conditions.
The basal expression of the Plonp-2GFP (bcIs126), Pctl-2GFP (bcSi76) and Pdaf-22GFP
(bcSi110) reporter is dependent on MDT-15. It might appear that GFP levels are gener-
ally reduced under mdt-15(RNAi) conditions. However, it has been shown that the basal
expression of the transcriptional UPRmt reporter Phsp-6GFP (zcIs13) is not affected by
mdt-15(RNAi) [Hou et al., 2014].
4.3.5 Reduced peroxisomal biogenesis leads to an import defect in intestinal cells
and induces an increase in the peroxisomal number in hypodermal cells
Knock-down of prx-5 by RNAi impairs peroxisomal matrix protein import [Petriv et al.,
2002]. In contrast to the study by Petriv et al., we use milder RNAi conditions leading to
a partial knock-down of prx-5 (∼60% reduction of PRX-5 protein). Therefore, I analyzed
the effect of the partial reduction of PRX-5 on peroxisomal matrix protein import. Flu-
orescence microscopy analysis of the import of the peroxisomal thiolase DAF-22 fused
to mKate2 revealed that our prx-5(RNAi) condition leads to a partial block of peroxiso-
mal matrix protein import in the intestine. In contrast, the import was not affected in













peroxisomes labeled with the peroxisomal membrane marker mKate2::PXMP-4, whereas
the number of peroxisomes importing GFP::PTS1 was similar to control RNAi condi-
tions. This indicates that a subset of the hypodermal peroxisomes might not be import
competent. A concurrent increase in the fluorescence intensity of some peroxisomes la-
beled by GFP::PTS1 indicates that the import of some peroxisomes might be actually
increased to compensate for the non-functional peroxisomes. It is conceivable that the
peroxisomes that do not show a GFP::PTS1 signal might undergo pexophagy. Red fluo-
rescent proteins are more stable in lysosomes than GFP. This could explain an increase in
mKate2-labeled peroxisomal membranes while the number of GFP::PTS1-labeled perox-
isomes remains constant. Using a mCherry::GFP::PTS1 tandem reporter could reveal if
the increase in mKate2-labeled peroxisomes is indeed due to increased pexophagy. The
proteomic analysis of prx-5(RNAi) treated animals showed that there was no significant
increase in peroxisomal membrane proteins compared to the control. This supports the
idea that the number of peroxisomes does not increase due to a de novo formation but
that they arise by division. However, the homologs of proteins involved in peroxisomal
fission like DRP-1, MFF-2, FIS-2 and PRX-11 were not significantly up-regulated upon
prx-5(RNAi).
Interestingly, knock-down of prx-5 as well as the loss of function by a mutation in
prx-5 induce the peroxisomal retrograde signaling. The RNAi treatment only leads to
impaired peroxisomal matrix protein import in the intestine whereas the import in hy-
podermal cells is not affected. In contrast, in the prx-5 mutant, the peroxisomal import
is almost completely blocked in hypodermal cells. Due to the high cytosolic signal of
GFP::PTS1 in the mutant, it cannot be excluded that some of the peroxisomes are still
import competent but their signal is not visible by fluorescent microscopy. Also the effect
on the mKate2::PXMP-4 labeled peroxisomes is different in the two cases. The number
of peroxisomes increases upon RNAi treatment, whereas fewer and enlarged peroxisomes
are visible in the mutant. Although the effects on import and morphology are very dif-
ferent, both conditions induce the PRS. This indicates that already a minor defect in per-
oxisomal biogenesis is sufficient to induce the PRS, but that a strong peroxisomal import
defect also induces the same pathway. Analyzing the proteome of the prx-5(tm4948) loss
96
4.3 THE PEROXISOMAL RETROGRADE SIGNALING PATHWAY
of function mutant would give insights if the response is similar in both cases or if there
are differences in the PRS depending on the severity of the peroxisomal import defect.
PRX-19 is a homolog of the mammalian import receptor for peroxisomal membrane
proteins PEX19. Peroxisomal membrane proteins can be imported in a PEX19 dependent
or independent manner. To study the function of PRX-19 for peroxisomal membrane
protein insertion in C. elegans, we generated a fusion construct of the homolog of the
mammalian peroxisomal membrane protein PXMP4 to target mKate2 to the peroxisomal
membrane in hypodermal cells. PXMP4 has been shown to be imported in a PEX19
dependent manner [Pinto et al., 2006]. If this is conserved for the C. elegans protein
PXMP-4, a knock-down of prx-19 would lead to a disrupted insertion of PXMP-4 into
the peroxisomal membrane and the signal intensity of the peroxisomes labeled by mKate2
would be decreased or even absent. Indeed, a fraction of peroxisomes showed a very weak
mKate2 signal upon prx-19(RNAi). This indicates that PXMP-4 is imported in a PRX-19
dependent manner similar to its mammalian homolog.
4.3.6 Lipids are potential signaling molecules in the PRS
We hypothesized that a block in peroxisomal biogenesis would also lead to a perturba-
tion of peroxisomal beta-oxidation. In C. elegans, peroxisomal beta-oxidation has a dual
role. The shortening of very long chain fatty acids has either metabolic functions or it
contributes to the biosynthesis of ascaroside pheromones. Specifically the knock-down of
acox-1.1, dhs-28, maoc-1 and daf-22 induced the PRS. These enzymes have been stud-
ied in the context of ascaroside biosynthesis and lack of these genes leads to a change in
the ascaroside and fatty acid composition of C. elegans [Butcher et al., 2009, von Reuss
et al., 2012, Artyukhin et al., 2018, Zhang et al., 2018]. In contrast, knock-down of genes
that are only predicted by sequence homology to code for peroxisomal beta-oxidation
enzymes [Gilst et al., 2005] (e.g. ech-6, ech-8 and ech-9) did not induce the PRS. Anal-
ysis of the lipid content of prx-5(RNAi) treated animals using the fat-soluble dye Oil Red
O did not show an accumulation of lipids compared to control animals. This indicates
that lipids do not accumulate upon knock-down of prx-5. However, the approach is not













the lipids not generally accumulate but the fatty acid or ascaroside composition might be
changed. To test this hypothesis, the metabolome of prx-5(RNAi) treated animals could
be analyzed by mass spectrometry.
The lipids might act as signaling molecules in the PRS. It has been shown that lipid
binding proteins can provide a link between lipids and nuclear hormone receptors like
NHR-49 [Xu et al., 2011, Folick et al., 2015]. Identifying the lipid binding protein in-
volved in the PRS would support the hypothesis that lipids are the signaling molecules.
Moreover, based on the results of the metabolic analysis, different lipids or ascarosides
could be fed to the PRS reporter strains to test if they can induce the signaling.
Many metabolic pathways taking place in peroxisomes generate hydrogen peroxide
and other reactive oxygen species (ROS). Hydrogen peroxide derived from peroxisomes
can act as cellular signaling molecule regulating various biological processes [Brown
et al., 1999, Koepke et al., 2008, Ivashchenko et al., 2011]. Thus, one could speculate
that ROS and not fatty acids are the signaling molecules in the PRS. It is conceivable that
the knock-down of prx-5 might result in a decreased import of the peroxisomal catalase
CTL-2 and thus in a disruption of the redox balance between peroxisomes and the cytosol.
However, a disrupted redox balance between the peroxisome and the cytosol caused by
the knock-down of genes coding for the cytosolic catalase CTL-1 or the peroxisomal cata-
lase CTL-2 did not induce the PRS. However, it would be necessary to confirm that the
knock-down of the catalases leads to a disrupted redox balance using redox sensors tar-
geted to the peroxisome and the cytosol. Another possibility to induce a redox imbalance
would be to target the photosensitizer KillerRed to peroxisomes, where it would produce
ROS upon green light illumination [Ivashchenko et al., 2011].
Miranda-Vizuete and Veal provide in their review a list of 14 ROS metabolizing en-
zymes in C. elegans [Miranda-Vizuete and Veal, 2017]. We identified 12 proteins of this
list in our prx-5(RNAi) proteome and three of them (CTL-1, CTL-2 and SOD-3) were
significantly up-regulated upon prx-5(RNAi). Interestingly, CTL-1 localizes to the cy-
tosol, CTL-2 localizes to peroxisomes and SOD-3 localizes to mitochondria [Taub et al.,
1999, Hunter et al., 1997]. This suggests that upon perturbation of peroxisomal matrix
protein import, ROS are produced in several compartments of the cell and, therefore, ROS
98
4.3 THE PEROXISOMAL RETROGRADE SIGNALING PATHWAY
scavenging enzymes localizing to these compartments are up-regulated. Zhou et al. ob-
serve reduced ROS levels in C. elegans animals treated with prx-5(RNAi) [Zhou et al.,
2012], which could be explained by the up-regulation of ROS scavenging enzymes. It
would be interesting, if we can reproduce under our RNAi conditions the observation that
prx-5(RNAi) leads to a decreased ROS level.
4.3.7 RNA-seq and proteomic analysis of the PRS show similar results
We identified the peroxisomal Lon protease and peroxisomal catalase as effector genes of
the PRS. To identify further effectors, we analyzed the effect of the knock-down of prx-5
on the C. elegans transcriptome by RNA-seq and on the proteome by mass spectrom-
etry. GO enrichment analysis of both datasets showed similar results. For instance, the
GO terms ”lipid metabolic process” (GO:0006629) and “immune response” (GO:006955)
were enriched in both analyses and will be discussed in more detail below (see chapters
4.3.8 and 4.3.9). However, it is not possible to compare the two datasets directly because
the samples for the two experiments were prepared separately and the RNAi protocol was
slightly different. To be able to compare multi-omics data, it should ideally be generated
from the same set of samples (i.e. under the same conditions). Besides the experimen-
tal design, there are also biological reasons why the two datasets can differ. Changes at
the mRNA level are not always reflected by changes at the protein level because of post-
transcriptional and/or translation regulation. Furthermore, the transcriptional response
may precede the change in protein levels. Therefore, conducting a time course experi-
ment can reveal these differences between the transcriptome and the proteome.
To identify if specifically peroxisomal proteins were changed, we generated a list of
peroxisomal proteins in C. elegans. The list includes 62 proteins that have a clear PTS1
sequence or a PEX19 targeting prediction in C. elegans and/or the mammalian homolog
localizes to peroxisomes. This number of proteins is consistent with a proteomic study
of human liver peroxisomes [Gronemeyer et al., 2013]. We observed that under our prx-
5(RNAi) conditions about 60% of peroxisomal genes but only 25% of peroxisomal pro-
teins were up-regulated. It is conceivable that activation of the PRS induces a general













levels of some proteins are regulated post-trancriptionally and/or post-translationally. Sur-
prisingly, upon prx-5(RNAi), the prx-5 transcripts were also increased 4.3-fold, whereas
the change in PRX-5 protein level is 0.4-fold. One explanation might be that we analyzed
the transcriptome and the proteome at the same time point. It is conceivable that the gene
was knocked-down at an earlier time point leading to reduced protein levels. In turn the
PRS was activated, which leads to a general transcriptional up-regulation of peroxiso-
mal genes, including prx-5. Supporting this notion, it has been shown for mitochondria
that the induction of UPRmt by knock-down of the gene encoding the protease SPG-7 by
RNAi leads to the transcriptional up-regulation of spg-7 [Nargund et al., 2012]. Since the
protein levels of PRX-5 are nevertheless decreased and we see a reduction of peroxisomal
matrix protein import by fluorescence microscopy, our RNAi conditions are still suitable
to study the PRS induced by reduced peroxisomal matrix protein import.
4.3.8 The PRS induces a compensatory up-regulation of the peroxisomal lipid
metabolism
25% of the peroxisomal proteins were significantly changed in the prx-5(RNAi) proteome
and all of them play a role in peroxisomal lipid metabolism. Futhermore, genes encoding
proteins involved in lipid metabolism were significantly enriched in the RNA-seq dataset.
We hypothesize that the defect in peroxisomal matrix protein import by prx-5(RNAi) leads
to perturbation of peroxisomal lipid metabolism, which in turn activates a compensatory
up-regulation of the respective enzymes. Since the amount of PRX-5 molecules is only
decreased by 60% in our RNAi conditions, an increase in the level of peroxisomal lipid
metabolism enzymes could increase their chance to be recognized by the few PRX-5
receptors and thus being imported into the remaining functional peroxisomes. In support
this notion, I did not observe an accumulation of lipids stained by the fat-soluble dye Oil
Red O upon the induction of the PRS, indicating that the function of peroxisomes in beta-
oxidation is maintained. Why no other peroxisomal metabolic pathways are up-regulated
requires further investigation. Interestingly, KEGG pathway enrichment analysis of the
RNA-seq data showed an enrichment on genes assigned to several amino acid metabolism
pathways. However, the levels of the respective proteins were not significantly changed.
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4.3.9 The PRS induces the innate immune response
GO enrichment analysis of the prx-5(RNAi) transcriptome and proteome showed that not
only the peroxisomal fatty acid metabolism but also the innate immune response was up-
regulated. Interestingly, MAOC-1 was the only protein assigned to GO terms of both
processes. MAOC-1 is required for peroxisomal beta-oxidation and for the resistance to
the pathogen Pseudomonas aeruginosa [Shapira et al., 2006]. However, one of the caveats
of GO terms is that the automated assignments can be incomplete and, therefore, man-
ual assignments are still necessary. Literature research revealed that MAOC-1 is not the
only protein significantly up-regulated upon prx-5(RNAi) that has a dual role in peroxiso-
mal beta-oxidation and innate immune response. Among the beta-oxidation enzymes that
were identified in the proteomic analysis, the genes coding for ACS-7, ACOX-1.5, CTL-
2, DHS-18, DHS-28, MAOC-1 and DAF-22 have been shown to be up-regulated upon
infection with different bacteria [Troemel et al., 2006, Wong et al., 2007]. Moreover,
ZK550.6, which encodes a homolog of a peroxisomal alpha-oxidation enzyme, is also
up-regulated [Troemel et al., 2006]. A link between lipid metabolism and the immune
response has previously been described in C. elegans [Nandakumar and Tan, 2008]. We
hypothesize that the cell tries to compensate for the peroxisomal defect upon prx-5(RNAi)
by an up-regulation of both pathways. It would be interesting to test, if the up-regulation
of the immune response effectors by the PRS is sufficient to maintain the immune re-
sponse in the animal. In this case, the animals would be not more susceptible to an in-
fection by a pathogen compared to untreated animals. However, it has been shown in the
fruit fly Drosophila melanogaster that in infected animals a knock-down of Pex5 leads to
a reduced survival compared to animals without RNAi treatment. This indicates that the
immune response is impaired due to peroxisomal dysfunction [Di Cara et al., 2017]. A
killing assay in C. elegans could reveal if the PRS is sufficient to restore the immune func-
tion of peroxisomes or if the damage is too strong and the animals also show a reduced
survival.
Similar to the PRS, the mitochondrial unfolded protein response in C. elegans also













by the exposure of C. elegans to various pathogens. It has been proposed that UPRmt is
induced to reduce mitochondrial damage caused by pathogen exposure [Pellegrino et al.,
2014, Liu et al., 2014]. The UPRmt transcription factor ATFS-1 has been shown to be
required for the regulation of immune response genes upon mitochondrial dysfunction
[Pellegrino et al., 2014]. Remarkably, also the PRS transcription factor MDT-15 is re-
quired for the activation of a detoxification response in C. elegans animals with dysfunc-
tional mitochondria [Mao et al., 2019]. Moreover, NHR-49 and MDT-15 play a role in
the regulation of immune response genes [Pukkila-Worley et al., 2014, Dasgupta et al.,
2019]. C. elegans lacking ATFS-1, NHR-49 or MDT-15 show a reduced survival when
challenged by a pathogen [Pellegrino et al., 2014, Sim and Hibberd, 2016, Mao et al.,
2019]. Given the parallels between the UPRmt and the PRS, one can speculate that the
PRS similarly functions in the restoration of peroxisomal function upon pathogen infec-
tion. To test this hypothesis, the transcriptional PRS reporter strains could be exposed to a
pathogen and then be analyzed to test if the peroxisomal retrograde signaling is induced.
Interestingly, the immune response genes up-regulated by UPRmt and PRS overlap but
are yet distinct. This indicates that some of the genes are more involved in a general stress
response, like for example the UDP-glucuronosyl transferases, whereas other genes are
more organelle stress specific.
4.4 The mitochondrial chaperone hsp-6 is induced by a perturbation
of peroxisomal biogenesis
The disruption of peroxisomal biogenesis by prx-5(RNAi) not only induced the peroxiso-
mal retrograde signaling, but also the mitochondrial unfolded protein response reporter
Phsp-6GFP (zcIs13). Subsequent knock-down of all peroxins showed that the knock-
down of prx-12 also induces the response and upon prx-19(RNAi), the reporter was also
slightly up-regulated, albeit not significantly. Peroxisomes and mitochondria exhibit a
functional interplay in several metabolic pathways like the degradation of fatty acids or
redox metabolism (reviewed in [Lismont et al., 2015, Wanders et al., 2016]). Defects in
peroxisomal lipid or ROS metabolism have an impact on the mitochondrial redox bal-
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ance. For example, the inhibition of a peroxisomal very long chain fatty acid transporter
ABCD1 impairs mitochondrial oxidative phosphorylation triggering mitochondrial ROS
production [López-Erauskin et al., 2013]. Moreover, the inhibition of peroxisomal cata-
lase activity leads to an increase in mitochondrial ROS levels [Walton, 2012]. Also im-
paired peroxisomal biogenesis by a loss of peroxins compromises mitochondrial function.
For instance, it has been shown in mammals that a loss of PEX5 among others depletes
mitochondrial DNA and impairs mitochondrial oxidative phosphorylation [Peeters et al.,
2015]. Depletion of mitochondrial DNA in mammals causes the induction of UPRmt
[Martinus et al., 1996]. Thus, depleted mitochondrial DNA could be a reason for the
induction of UPRmt reporter Phsp-6GFP (zcIs13) carrying the prx-5(tm4948) mutation.
In contrast to hsp-6, another UPRmt target gene hsp-60 was not up-regulated upon the
knock-down of the peroxins and the endogenous HSP-60 levels were even decreased in
the prx-5(tm4948) mutant. It has previously been described that some UPRmt inducers
only up-regulate the expression of the Phsp-6GFP (zcIs13) reporter but not the Phsp-60GFP
(zcIs9) reporter [Bennett et al., 2014]. This could be due to the different functions of HSP-
6 and HSP-60 in mitochondria or due to different sensitivities of the reporters. Analysis
of the hsp-6 or hsp-60 mRNA levels would be necessary to rule out the latter possibility.
4.5 Conclusion and future perspective
In this study, I have demonstrated that perturbation of peroxisomal biogenesis leads to the
induction of a peroxisomal retrograde signaling to restore peroxisomal function. To my
knowledge, it is the first description of a peroxisomal stress signaling pathway. Organel-
lar stress response pathways generally consist of four parts. First, there can be several
genetic defects or external cues that induce the organellar stress and, hence, the signal-
ing. Second, the stress is recognized and the information is transmitted to the nucleus
by signaling molecules. Third, the transcriptional response is activated through transcrip-
tion factors. Finally, the protein levels of effector proteins is adjusted according to the
needs of the organelle. I was able to shed light on three of the four parts of the perox-













induce the response: the perturbation of peroxisomal biogenesis and the perturbation of
peroxisomal beta oxidation. It is conceivable that the perturbation of beta-oxidation is a
downstream effect of a perturbed biogenesis. Moreover, I identified the nuclear hormone
receptor NHR-49 and its co-factor MDT-15 to be required for the transcriptional response.
Finally, using a global transcriptomic and proteomic approach, we identified two groups
of effector proteins. The innate immune response and peroxisomal lipid metabolism are
up-regulated upon peroxisomal stress. Taken together, the main question that remains to
be answered is how the signal is transmitted from the peroxisome to the nucleus. Genetic
screens could provide candidates in this regard. We suggest that lipids might act as sig-
naling molecules in the PRS. The comparison of the lipid composition of animals under
stressed and unstresed conditions could pinpoint at possible signaling lipids in the PRS.
Organellar stress response pathways are essential to maintain cellular functions. Ac-
cordingly, the mitochondrial and endoplasmic reticulum unfolded protein responses are
induced in several diseases. Both stress response pathways have been shown to be con-
served from C. elegans to mammals. To study the physiological relevance of the per-
oxisomal retrograde signaling for humans, it would be necessary to show that it is also
conserved. Peroxisomal diseases are caused by mutations in peroxisomal proteins. For
example, the Zellweger syndrome is caused by a defect in peroxisomal biogenesis due to
mutations in peroxins (reviewed in [Waterham and Ebberink, 2012]). Since the PRS is
induced in the prx-5 loss of function mutant, studying the PRS in patient cell lines could
contribute to our understanding of the pathology of the Zellweger syndrome caused by a
mutation in PEX5.
In the past decade, peroxisomes have emerged as important factors in the immune
response and inflammation. Peroxisomal metabolites play a central role in the modulation
of the immune response (reviwed in [Di Cara et al., 2019]). The PRS also displays a link
between peroxisomal metabolism and the innate immune response in C. elegans. Further
investigation of the role of the PRS in immune function could offer new opportunities to
find novel therapeutic targets to treat infections.
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Table A.1: Gene set enrichment analysis of KEGG pathways in prx-5(RNAi) samples compared
to tag-208(RNAi) control samples.
Pathway Description p-value Enrichment
cel04146 Peroxisome 0.0000 2.03
cel03050 Proteasome 0.0000 -2.32
cel03040 Spliceosome 0.0000 -2.34
cel03010 Ribosome 0.0000 -2.96
cel04142 Lysosome 0.0000 1.94
cel03008 Ribosome biogenesis in eukaryotes 0.0000 -2.15
cel00970 Aminoacyl-tRNA biosynthesis 0.0000 -2.00
cel04140 Autophagy 0.0000 1.81
cel00980 Metabolism of xenobiotics by cytochrome P450 0.0000 1.79
cel00830 Retinol metabolism 0.0000 1.77
cel02010 ABC transporters 0.0014 1.75
cel00062 Fatty acid elongation 0.0000 1.81
cel00982 Drug metabolism 0.0012 1.77
cel03018 RNA degradation 0.0000 -1.91
cel00053 Ascorbate and aldarate metabolism 0.0028 1.71
cel00600 Sphingolipid metabolism 0.0040 1.71
cel03020 RNA polymerase 0.0033 -1.88
cel00860 Porphyrin and chlorophyll metabolism 0.0086 1.65
cel03030 DNA replication 0.0000 -1.76
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Table A.2: KEGG pathway enrichment analysis using DAVID of genes significantly changed
(FDR<0.05 and log2(fold change) ≥1 or log2(fold change) ≤-1) upon knock-down of prx-5.
Pathway Description p-value Enrichment
cel04146 Peroxisome 1.96E-15 7.27
cel04142 Lysosome 2.19E-13 5.76
cel01212 Fatty acid metabolism 1.72E-06 5.32
cel00982 Drug metabolism - cytochrome P450 4.64E-06 6.00
cel00071 Fatty acid degradation 3.76E-05 4.87
cel00980 Metabolism of xenobiotics by cytochrome P450 8.62E-05 5.66
cel01040 Biosynthesis of unsaturated fatty acids 6.43E-04 7.55
cel02010 ABC transporters 1.88E-03 6.14
cel00600 Sphingolipid metabolism 4.43E-03 4.24
cel00062 Fatty acid elongation 7.91E-03 5.84
cel00592 alpha-Linolenic acid metabolism 9.65E-03 8.18
cel00310 Lysine degradation 1.75E-02 3.78
cel00380 Tryptophan metabolism 5.27E-02 3.41
cel00480 Glutathione metabolism 5.61E-02 2.81
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Table A.3: GO enrichment analysis of the domain biological process using GOrilla and REVIGO
of genes significantly changed (FDR<0.05 and log2(fold change) ≥1 or log2(fold change) ≤-1)
upon knock-down of prx-5.
GO Term Description p-value Enrichment
GO:0006952 Defense response 1.05E-35 3.75
GO:0006955 Immune response 2.65E-30 4.27
GO:0002376 Immune system process 3.05E-30 4.22
GO:0051707 Response to other organism 6.03E-13 3.15
GO:0009607 Response to biotic stimulus 7.78E-13 3.13
GO:0006950 Response to stress 1.87E-12 1.80
GO:0051704 Multi-organism process 2.07E-11 2.80
GO:0006629 Lipid metabolic process 3.70E-10 2.04
GO:0050896 Response to stimulus 2.52E-09 1.59
GO:0009605 Response to external stimulus 1.28E-08 2.26
GO:0016042 Lipid catabolic process 5.75E-08 3.02
GO:0006631 Fatty acid metabolic process 1.16E-07 2.87
GO:0007031 Peroxisome organization 5.76E-06 7.47
GO:0072329 Monocarboxylic acid catabolic process 7.79E-06 3.56
GO:0032787 Monocarboxylic acid metabolic process 8.86E-06 2.28
GO:0044242 Cellular lipid catabolic process 8.98E-06 3.10
GO:0043574 Peroxisomal transport 1.58E-05 8.01
GO:0015919 Peroxisomal membrane transport 1.58E-05 8.01
GO:0019395 Fatty acid oxidation 1.82E-05 4.64
GO:0055114 Oxidation-reduction process 2.59E-05 1.61
GO:0097501 Stress response to metal ion 3.72E-05 5.34
GO:0016558 Protein import into peroxisome matrix 3.95E-05 8.90
GO:1990170 Stress response to cadmium ion 1.27E-04 7.63
GO:0042338 Cuticle development involved in collagen
and cuticulin-based cuticle molting cycle
1.90E-04 4.00
GO:0046686 Response to cadmium ion 3.31E-04 4.67
GO:1905952 Regulation of lipid localization 5.28E-04 3.56
GO:0016119 Carotene metabolic process 8.19E-04 10.68
GO:0042214 Terpene metabolic process 8.19E-04 10.68
GO:0006876 Cellular cadmium ion homeostasis 9.82E-04 7.12
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Table B.1: Significantly changed proteins upon knock-down of prx-5. Proteins with a log2(fold
change) value ≥1 (increased) or ≤-1 (decreased) and a p-value <0.05 were considered as signifi-
cantly changed.
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Table B.1 continued from previous page
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Table B.2: GO enrichment analysis using GOrilla and REVIGO of proteins significantly changed
(p<0.05 and log2(fold change) ≥1 or log2(fold change) ≤-1) upon knock-down of prx-5.
GO domain GO Term Description p-value Enrichment
Biological
process
GO:0006629 Lipid metabolic process 1.29E-05 3.01
GO:0006955 Immune response 2.11E-05 4.60
GO:0002376 Immune system process 2.88E-05 4.46
GO:0044255 Cellular lipid metabolic process 5.73E-05 3.04
GO:0044242 Cellular lipid catabolic process 7.39E-05 5.58
GO:0019395 Fatty acid oxidation 1.10E-04 7.54
GO:0006952 Defense response 1.37E-04 3.50
GO:0072329 Monocarboxylic acid catabolic
process
6.53E-04 5.51


















GO:0070001 Aspartic-type peptidase activity 2.96E-05 12.56
GO:0003997 Acyl-CoA oxidase activity 3.45E-04 18.84
GO:0016634 Oxidoreductase activity. Acting





GO:0042579 Microbody 5.35E-07 8.69
GO:0005777 Peroxisome 1.90E-05 7.99
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Moser, A. B., Schlüter, A., Murphy, M. P., Lizcano, J. M., Miranda-Vizuete, A., et al.
(2020). The peroxisomal fatty acid transporter abcd1/pmp-4 is required in the c. ele-
gans hypodermis for axonal maintenance: A worm model for adrenoleukodystrophy.
Free Radical Biology and Medicine.
[Corsi et al., 2015] Corsi, A. K., Wightman, B., and A, C. M. (2015). Transparent win-
dow into biology: a primer on Caenorhabditis elegans. WormBook.
[Cuppen et al., 2003] Cuppen, E., van der Linden, A. M., Jansen, G., and Plasterk, R.
H. A. (2003). Proteins interacting with Caenorhabditis elegans gα subunits. Compar-
ative and functional genomics, 4(18629017):479–491.
[Danpure and Jennings, 1986] Danpure, C. J. and Jennings, P. R. (1986). Peroxisomal














[Danpure et al., 1994] Danpure, C. J., Jennings, P. R., Fryer, P., Purdue, P. E., and Allsop,
J. (1994). Primary hyperoxaluria type 1: Genotypic and phenotypic heterogeneity.
Journal of Inherited Metabolic Disease, 17(4):487–499.
[Dasgupta et al., 2019] Dasgupta, M., Shashikanth, M., Bojanala, N., Gupta, A., Javed,
S., and Singh, V. (2019). Nuclear hormone receptor NHR-49 shapes immuno-
metabolic response of Caenorhabditis elegans to Enterococcus faecalis infection.
bioRxiv, page 549907.
[De Duve and Baudhuin, 1966] De Duve, C. A. B. P. and Baudhuin, P. (1966). Peroxi-
somes (microbodies and related particles). Physiological reviews, 46(2):323–357.
[Delille et al., 2010] Delille, H. K., Agricola, B., Guimaraes, S. C., Borta, H., Lüers,
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C. B. L. M., Barth, P. G., Wanders, R. J. A., and Poll-The, B. T. (2006a). Clinical and
biochemical spectrum of d-bifunctional protein deficiency. Ann Neurol., 59(1):92–104.
[Ferdinandusse et al., 2018] Ferdinandusse, S., Denis, S., van Roermund, C. W., Preece,
M. A., Koster, J., Ebberink, M. S., Waterham, H. R., and Wanders, R. J. (2018). A













acyl-CoA oxidase. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease,
1864(3):952–958.
[Ferdinandusse et al., 2017] Ferdinandusse, S., Falkenberg, K. D., Koster, J., Mooyer,
P. A., Jones, R., van Roermund, C. W. T., Pizzino, A., Schrader, M., Wanders, R.
J. A., Vanderver, A., and Waterham, H. R. (2017). Acbd5 deficiency causes a defect in
peroxisomal very long-chain fatty acid metabolism. J Med Genet, 54(5):330.
[Ferdinandusse et al., 2014] Ferdinandusse, S., Jimenez-Sanchez, G., Koster, J., Denis,
S., Van Roermund, C. W., Silva-Zolezzi, I., Moser, A. B., Visser, W. F., Gulluoglu, M.,
Durmaz, O., Demirkol, M., Waterham, H. R., Gökcay, G., Wanders, R. J. A., and Valle,
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